TermID	Term	Enrichment	logP	Genes in Term	Target Genes in Term	Fraction of Targets in Term	Total Target Genes	Total Genes	Entrez Gene IDs	Gene Symbols
SMP00092	Rosuvastatin Action Pathway	0.0105281738580689	-4.55370039066121	21	6	0.0645161290322581	93	978	6713,3422,4598,2224,3156,2222	SQLE,IDI1,MVK,FDPS,HMGCR,FDFT1
SMP00508	Cholesteryl ester storage disease	0.0105281738580689	-4.55370039066121	21	6	0.0645161290322581	93	978	6713,3422,4598,2224,3156,2222	SQLE,IDI1,MVK,FDPS,HMGCR,FDFT1
SMP00510	Mevalonic aciduria	0.0105281738580689	-4.55370039066121	21	6	0.0645161290322581	93	978	6713,3422,4598,2224,3156,2222	SQLE,IDI1,MVK,FDPS,HMGCR,FDFT1
SMP00387	CHILD Syndrome	0.0105281738580689	-4.55370039066121	21	6	0.0645161290322581	93	978	6713,3422,4598,2224,3156,2222	SQLE,IDI1,MVK,FDPS,HMGCR,FDFT1
SMP00095	Alendronate Action Pathway	0.0105281738580689	-4.55370039066121	21	6	0.0645161290322581	93	978	6713,3422,4598,2224,3156,2222	SQLE,IDI1,MVK,FDPS,HMGCR,FDFT1
SMP00107	Zoledronate Action Pathway	0.0105281738580689	-4.55370039066121	21	6	0.0645161290322581	93	978	6713,3422,4598,2224,3156,2222	SQLE,IDI1,MVK,FDPS,HMGCR,FDFT1
SMP00389	Smith-Lemli-Opitz Syndrome (SLOS)	0.0105281738580689	-4.55370039066121	21	6	0.0645161290322581	93	978	6713,3422,4598,2224,3156,2222	SQLE,IDI1,MVK,FDPS,HMGCR,FDFT1
SMP00112	Risedronate Action Pathway	0.0105281738580689	-4.55370039066121	21	6	0.0645161290322581	93	978	6713,3422,4598,2224,3156,2222	SQLE,IDI1,MVK,FDPS,HMGCR,FDFT1
SMP00119	Fluvastatin Action Pathway	0.0105281738580689	-4.55370039066121	21	6	0.0645161290322581	93	978	6713,3422,4598,2224,3156,2222	SQLE,IDI1,MVK,FDPS,HMGCR,FDFT1
SMP00079	Ibandronate Action Pathway	0.0105281738580689	-4.55370039066121	21	6	0.0645161290322581	93	978	6713,3422,4598,2224,3156,2222	SQLE,IDI1,MVK,FDPS,HMGCR,FDFT1
SMP00209	Hypercholesterolemia	0.0105281738580689	-4.55370039066121	21	6	0.0645161290322581	93	978	6713,3422,4598,2224,3156,2222	SQLE,IDI1,MVK,FDPS,HMGCR,FDFT1
SMP00388	Chondrodysplasia Punctata II- X Linked Dominant (CDPX2)	0.0105281738580689	-4.55370039066121	21	6	0.0645161290322581	93	978	6713,3422,4598,2224,3156,2222	SQLE,IDI1,MVK,FDPS,HMGCR,FDFT1
SMP00386	Desmosterolosis	0.0105281738580689	-4.55370039066121	21	6	0.0645161290322581	93	978	6713,3422,4598,2224,3156,2222	SQLE,IDI1,MVK,FDPS,HMGCR,FDFT1
SMP00511	Wolman disease	0.0105281738580689	-4.55370039066121	21	6	0.0645161290322581	93	978	6713,3422,4598,2224,3156,2222	SQLE,IDI1,MVK,FDPS,HMGCR,FDFT1
SMP00023	Steroid Biosynthesis	0.0105281738580689	-4.55370039066121	21	6	0.0645161290322581	93	978	6713,3422,4598,2224,3156,2222	SQLE,IDI1,MVK,FDPS,HMGCR,FDFT1
SMP00099	Lovastatin Action Pathway	0.0105281738580689	-4.55370039066121	21	6	0.0645161290322581	93	978	6713,3422,4598,2224,3156,2222	SQLE,IDI1,MVK,FDPS,HMGCR,FDFT1
SMP00509	Hyper-IgD syndrome	0.0105281738580689	-4.55370039066121	21	6	0.0645161290322581	93	978	6713,3422,4598,2224,3156,2222	SQLE,IDI1,MVK,FDPS,HMGCR,FDFT1
SMP00131	Atorvastatin Action Pathway	0.0105281738580689	-4.55370039066121	21	6	0.0645161290322581	93	978	6713,3422,4598,2224,3156,2222	SQLE,IDI1,MVK,FDPS,HMGCR,FDFT1
SMP00082	Simvastatin Action Pathway	0.0105281738580689	-4.55370039066121	21	6	0.0645161290322581	93	978	6713,3422,4598,2224,3156,2222	SQLE,IDI1,MVK,FDPS,HMGCR,FDFT1
SMP00117	Pamidronate Action Pathway	0.0105281738580689	-4.55370039066121	21	6	0.0645161290322581	93	978	6713,3422,4598,2224,3156,2222	SQLE,IDI1,MVK,FDPS,HMGCR,FDFT1
SMP00319	Lysosomal Acid Lipase Deficiency (Wolman Disease)	0.0105281738580689	-4.55370039066121	21	6	0.0645161290322581	93	978	6713,3422,4598,2224,3156,2222	SQLE,IDI1,MVK,FDPS,HMGCR,FDFT1
SMP00111	Cerivastatin Action Pathway	0.0105281738580689	-4.55370039066121	21	6	0.0645161290322581	93	978	6713,3422,4598,2224,3156,2222	SQLE,IDI1,MVK,FDPS,HMGCR,FDFT1
SMP00089	Pravastatin Action Pathway	0.0105281738580689	-4.55370039066121	21	6	0.0645161290322581	93	978	6713,3422,4598,2224,3156,2222	SQLE,IDI1,MVK,FDPS,HMGCR,FDFT1
SMP00649	Lamivudine Metabolism Pathway	0.0220140101553178	-3.81607620306925	18	5	0.0537634408602151	93	978	8714,1244,30833,51727,10257	ABCC3,ABCC2,NT5C,CMPK1,ABCC4
SMP00428	Mercaptopurine Action Pathway	0.0688962045197917	-2.67515418927533	47	8	0.0860215053763441	93	978	3251,2618,957,10257,10846,471,353,132	HPRT1,GART,ENTPD5,ABCC4,PDE10A,ATIC,APRT,ADK
SMP00430	Thioguanine Action Pathway	0.0688962045197917	-2.67515418927533	47	8	0.0860215053763441	93	978	3251,2618,10257,957,10846,471,353,132	HPRT1,GART,ABCC4,ENTPD5,PDE10A,ATIC,APRT,ADK
SMP00427	Azathioprine Action Pathway	0.0688962045197917	-2.67515418927533	47	8	0.0860215053763441	93	978	3251,2618,10257,957,10846,471,353,132	HPRT1,GART,ABCC4,ENTPD5,PDE10A,ATIC,APRT,ADK
SMP00029	Selenoamino Acid Metabolism	0.078304107042753	-2.54715522470768	11	3	0.032258064516129	93	978	2678,22928,4141	GGT1,SEPHS2,MARS
SMP00647	Thioguanine Metabolism Pathway	0.095092024539981	-2.35291017688047	1	1	0.010752688172043	93	978	3251	HPRT1
SMP00445	Spermidine and Spermine Biosynthesis	0.104222870947981	-2.26122368288392	6	2	0.021505376344086	93	978	6723,4953	SRM,ODC1
SMP00203	Molybdenum Cofactor Deficiency	0.130633037662801	-2.0353631258093	37	6	0.0645161290322581	93	978	3251,353,2618,957,10846,471	HPRT1,APRT,GART,ENTPD5,PDE10A,ATIC
SMP00167	Adenylosuccinate Lyase Deficiency	0.130633037662801	-2.0353631258093	37	6	0.0645161290322581	93	978	3251,353,2618,957,10846,471	HPRT1,APRT,GART,ENTPD5,PDE10A,ATIC
SMP00365	Gout or Kelley-Seegmiller Syndrome	0.130633037662801	-2.0353631258093	37	6	0.0645161290322581	93	978	3251,353,2618,957,10846,471	HPRT1,APRT,GART,ENTPD5,PDE10A,ATIC
SMP00220	Xanthine Dehydrogenase Deficiency (Xanthinuria)	0.130633037662801	-2.0353631258093	37	6	0.0645161290322581	93	978	3251,353,2618,957,10846,471	HPRT1,APRT,GART,ENTPD5,PDE10A,ATIC
SMP00537	Myoadenylate deaminase deficiency	0.130633037662801	-2.0353631258093	37	6	0.0645161290322581	93	978	3251,353,2618,957,10846,471	HPRT1,APRT,GART,ENTPD5,PDE10A,ATIC
SMP00050	Purine Metabolism	0.130633037662801	-2.0353631258093	37	6	0.0645161290322581	93	978	3251,353,2618,957,10846,471	HPRT1,APRT,GART,ENTPD5,PDE10A,ATIC
SMP00144	Adenosine Deaminase Deficiency	0.130633037662801	-2.0353631258093	37	6	0.0645161290322581	93	978	3251,353,2618,957,10846,471	HPRT1,APRT,GART,ENTPD5,PDE10A,ATIC
SMP00536	Mitochondrial DNA depletion syndrome	0.130633037662801	-2.0353631258093	37	6	0.0645161290322581	93	978	3251,353,2618,957,10846,471	HPRT1,APRT,GART,ENTPD5,PDE10A,ATIC
SMP00535	Adenine phosphoribosyltransferase deficiency (APRT)	0.130633037662801	-2.0353631258093	37	6	0.0645161290322581	93	978	3251,353,2618,957,10846,471	HPRT1,APRT,GART,ENTPD5,PDE10A,ATIC
SMP00512	Xanthinuria type I	0.130633037662801	-2.0353631258093	37	6	0.0645161290322581	93	978	3251,353,2618,957,10846,471	HPRT1,APRT,GART,ENTPD5,PDE10A,ATIC
SMP00513	Xanthinuria type II	0.130633037662801	-2.0353631258093	37	6	0.0645161290322581	93	978	3251,353,2618,957,10846,471	HPRT1,APRT,GART,ENTPD5,PDE10A,ATIC
SMP00210	Purine Nucleoside Phosphorylase Deficiency	0.130633037662801	-2.0353631258093	37	6	0.0645161290322581	93	978	3251,353,2618,957,10846,471	HPRT1,APRT,GART,ENTPD5,PDE10A,ATIC
SMP00364	Lesch-Nyhan Syndrome (LNS)	0.130633037662801	-2.0353631258093	37	6	0.0645161290322581	93	978	3251,353,2618,957,10846,471	HPRT1,APRT,GART,ENTPD5,PDE10A,ATIC
SMP00168	AICA-Ribosiduria	0.130633037662801	-2.0353631258093	37	6	0.0645161290322581	93	978	353,3251,2618,957,10846,471	APRT,HPRT1,GART,ENTPD5,PDE10A,ATIC
SMP00582	Joubert syndrome	0.130769084441738	-2.03432222537494	21	4	0.043010752688172	93	978	23236,8867,5305,30849	PLCB1,SYNJ1,PIP4K2A,PIK3R4
SMP00463	Phosphatidylinositol Phosphate Metabolism	0.130769084441738	-2.03432222537494	21	4	0.043010752688172	93	978	23236,8867,5305,30849	PLCB1,SYNJ1,PIP4K2A,PIK3R4
SMP00044	Histidine Metabolism	0.140571051675226	-1.96204221216097	14	3	0.032258064516129	93	978	23438,3035,10196	HARS2,HARS,PRMT3
SMP00191	Histidinemia	0.140571051675226	-1.96204221216097	14	3	0.032258064516129	93	978	23438,3035,10196	HARS2,HARS,PRMT3
SMP00345	Congenital Erythropoietic Porphyria (CEP) or Gunther Disease	0.164171463502895	-1.80684388815801	15	3	0.032258064516129	93	978	210,1352,7389	ALAD,COX10,UROD
SMP00609	Mercaptopurine Metabolism Pathway	0.164171463502895	-1.80684388815801	15	3	0.032258064516129	93	978	3251,10257,132	HPRT1,ABCC4,ADK
SMP00344	Acute Intermittent Porphyria	0.164171463502895	-1.80684388815801	15	3	0.032258064516129	93	978	210,1352,7389	ALAD,COX10,UROD
SMP00024	Porphyrin Metabolism	0.164171463502895	-1.80684388815801	15	3	0.032258064516129	93	978	210,1352,7389	ALAD,COX10,UROD
SMP00342	Hereditary Coproporphyria (HCP)	0.164171463502895	-1.80684388815801	15	3	0.032258064516129	93	978	210,1352,7389	ALAD,COX10,UROD
SMP00346	Porphyria Variegata (PV)	0.164171463502895	-1.80684388815801	15	3	0.032258064516129	93	978	210,1352,7389	ALAD,COX10,UROD
SMP00580	GLUT-1 deficiency syndrome	0.207935159680341	-1.57052898018549	9	2	0.021505376344086	93	978	51727,6513	CMPK1,SLC2A1
SMP00444	Lactose Synthesis	0.207935159680341	-1.57052898018549	9	2	0.021505376344086	93	978	51727,6513	CMPK1,SLC2A1
SMP00466	Transfer of Acetyl Groups into Mitochondria	0.207935159680341	-1.57052898018549	9	2	0.021505376344086	93	978	4199,51660	ME1,MPC1
SMP00311	Excitatory Neural Signalling Through 5-HTR 7 and  Serotonin 	0.207935159680341	-1.57052898018549	9	2	0.021505376344086	93	978	3363,5567	HTR7,PRKACB
SMP00579	Congenital disorder of glycosylation CDG-IId	0.207935159680341	-1.57052898018549	9	2	0.021505376344086	93	978	51727,6513	CMPK1,SLC2A1
SMP00482	Mitochondrial Beta-Oxidation of Long Chain Saturated Fatty Acids	0.244658267363882	-1.40789286920042	10	2	0.021505376344086	93	978	1374,788	CPT1A,SLC25A20
SMP00437	Vincristine Action Pathway	0.244658267363882	-1.40789286920042	10	2	0.021505376344086	93	978	8714,1244	ABCC3,ABCC2
SMP00438	Vindesine Action Pathway	0.244658267363882	-1.40789286920042	10	2	0.021505376344086	93	978	8714,1244	ABCC3,ABCC2
SMP00654	Warburg Effect	0.250249514304515	-1.38529680162979	45	6	0.0645161290322581	93	978	6566,8802,2539,51660,3099,5226	SLC16A1,SUCLG1,G6PD,MPC1,HK2,PGD
SMP00564	Multiple carboxylase deficiency- neonatal or early onset form	0.259247709384089	-1.34997126745989	3	1	0.010752688172043	93	978	3141	HLCS
SMP00174	Biotinidase Deficiency	0.259247709384089	-1.34997126745989	3	1	0.010752688172043	93	978	3141	HLCS
SMP00066	Biotin Metabolism	0.259247709384089	-1.34997126745989	3	1	0.010752688172043	93	978	3141	HLCS
SMP00340	Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)	0.267481936118215	-1.31870324345627	19	3	0.032258064516129	93	978	253827,6723,4141	MSRB3,SRM,MARS
SMP00063	Tryptophan Metabolism	0.267481936118215	-1.31870324345627	19	3	0.032258064516129	93	978	847,10352,7453	CAT,WARS2,WARS
SMP00214	S-Adenosylhomocysteine (SAH) Hydrolase Deficiency	0.267481936118215	-1.31870324345627	19	3	0.032258064516129	93	978	253827,6723,4141	MSRB3,SRM,MARS
SMP00221	Methionine Adenosyltransferase Deficiency	0.267481936118215	-1.31870324345627	19	3	0.032258064516129	93	978	253827,6723,4141	MSRB3,SRM,MARS
SMP00177	Cystathionine Beta-Synthase Deficiency	0.267481936118215	-1.31870324345627	19	3	0.032258064516129	93	978	253827,6723,4141	MSRB3,SRM,MARS
SMP00341	Hypermethioninemia	0.267481936118215	-1.31870324345627	19	3	0.032258064516129	93	978	253827,6723,4141	MSRB3,SRM,MARS
SMP00033	Methionine Metabolism	0.267481936118215	-1.31870324345627	19	3	0.032258064516129	93	978	253827,6723,4141	MSRB3,SRM,MARS
SMP00222	Glycine N-methyltransferase Deficiency	0.267481936118215	-1.31870324345627	19	3	0.032258064516129	93	978	253827,6723,4141	MSRB3,SRM,MARS
SMP00570	Homocystinuria-megaloblastic anemia due to defect in cobalamin metabolism- cblG complementation type	0.267481936118215	-1.31870324345627	19	3	0.032258064516129	93	978	253827,6723,4141	MSRB3,SRM,MARS
SMP00436	Vinblastine Action Pathway	0.281625858546528	-1.26717583168922	11	2	0.021505376344086	93	978	8714,1244	ABCC3,ABCC2
SMP00439	Vinorelbine Action Pathway	0.281625858546528	-1.26717583168922	11	2	0.021505376344086	93	978	8714,1244	ABCC3,ABCC2
SMP00543	Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)	0.318463470608176	-1.1442475025156	12	2	0.021505376344086	93	978	25902,4522	MTHFD1L,MTHFD1
SMP00053	Folate Metabolism	0.318463470608176	-1.1442475025156	12	2	0.021505376344086	93	978	25902,4522	MTHFD1L,MTHFD1
SMP00432	Methotrexate Action Pathway	0.318463470608176	-1.1442475025156	12	2	0.021505376344086	93	978	25902,4522	MTHFD1L,MTHFD1
SMP00724	Folate malabsorption- hereditary	0.318463470608176	-1.1442475025156	12	2	0.021505376344086	93	978	25902,4522	MTHFD1L,MTHFD1
SMP00076	Thiamine Metabolism	0.329904081720701	-1.10895332822426	4	1	0.010752688172043	93	978	27010	TPK1
SMP00629	Adefovir Dipivoxil Metabolism Pathway	0.329904081720701	-1.10895332822426	4	1	0.010752688172043	93	978	204	AK2
SMP00129	Malate-Aspartate Shuttle	0.329904081720701	-1.10895332822426	4	1	0.010752688172043	93	978	8604	SLC25A12
SMP00630	Tenofovir Metabolism Pathway	0.329904081720701	-1.10895332822426	4	1	0.010752688172043	93	978	204	AK2
SMP00603	Gemcitabine Metabolism Pathway	0.354864273041365	-1.03601989207421	13	2	0.021505376344086	93	978	30833,51727	NT5C,CMPK1
SMP00446	Gemcitabine Action Pathway	0.354864273041365	-1.03601989207421	13	2	0.021505376344086	93	978	30833,51727	NT5C,CMPK1
SMP00358	Fc Epsilon Receptor I Signaling in Mast Cells	0.362474363533221	-1.01480152847594	32	4	0.043010752688172	93	978	4893,5163,5578,5606	NRAS,PDK1,PRKCA,MAP2K3
SMP00198	Malonic Aciduria	0.39057980993538	-0.940122951749105	14	2	0.021505376344086	93	978	26275,5095	HIBCH,PCCA
SMP00201	Methylmalonic Aciduria Due to Cobalamin-Related Disorders	0.39057980993538	-0.940122951749105	14	2	0.021505376344086	93	978	26275,5095	HIBCH,PCCA
SMP00067	Aspartate Metabolism	0.39057980993538	-0.940122951749105	14	2	0.021505376344086	93	978	790,440	CAD,ASNS
SMP00175	Canavan Disease	0.39057980993538	-0.940122951749105	14	2	0.021505376344086	93	978	790,440	CAD,ASNS
SMP00192	Hypoacetylaspartia	0.39057980993538	-0.940122951749105	14	2	0.021505376344086	93	978	790,440	CAD,ASNS
SMP00502	Malonyl-coa decarboxylase deficiency	0.39057980993538	-0.940122951749105	14	2	0.021505376344086	93	978	26275,5095	HIBCH,PCCA
SMP00016	Propanoate Metabolism	0.39057980993538	-0.940122951749105	14	2	0.021505376344086	93	978	26275,5095	HIBCH,PCCA
SMP00055	Alanine Metabolism	0.3938865461972	-0.931692364965076	5	1	0.010752688172043	93	978	16	AARS
SMP00070	Riboflavin Metabolism	0.3938865461972	-0.931692364965076	5	1	0.010752688172043	93	978	80308	FLAD1
SMP00468	Degradation of Superoxides	0.3938865461972	-0.931692364965076	5	1	0.010752688172043	93	978	847	CAT
SMP00352	Primary Hyperoxaluria Type I	0.3938865461972	-0.931692364965076	5	1	0.010752688172043	93	978	16	AARS
SMP00516	Adrenoleukodystrophy- X-linked	0.3938865461972	-0.931692364965076	5	1	0.010752688172043	93	978	788	SLC25A20
SMP00350	Pyruvate Carboxylase Deficiency	0.3938865461972	-0.931692364965076	5	1	0.010752688172043	93	978	16	AARS
SMP00052	Beta Oxidation of Very Long Chain Fatty Acids	0.3938865461972	-0.931692364965076	5	1	0.010752688172043	93	978	788	SLC25A20
SMP00313	Lactic Acidemia	0.3938865461972	-0.931692364965076	5	1	0.010752688172043	93	978	16	AARS
SMP00018	Alpha Linolenic Acid and Linoleic Acid Metabolism	0.3938865461972	-0.931692364965076	5	1	0.010752688172043	93	978	3992	FADS1
SMP00517	Carnitine-acylcarnitine translocase deficiency	0.3938865461972	-0.931692364965076	5	1	0.010752688172043	93	978	788	SLC25A20
SMP00310	Corticotropin Activation of Cortisol Production	0.3938865461972	-0.931692364965076	5	1	0.010752688172043	93	978	5567	PRKACB
SMP00465	Carnitine Synthesis	0.3938865461972	-0.931692364965076	5	1	0.010752688172043	93	978	55217	TMLHE
SMP00518	Glucose-6-phosphate dehydrogenase deficiency	0.425411863233137	-0.854697489361926	15	2	0.021505376344086	93	978	2539,5226	G6PD,PGD
SMP00031	Pentose Phosphate Pathway	0.425411863233137	-0.854697489361926	15	2	0.021505376344086	93	978	2539,5226	G6PD,PGD
SMP00519	Ribose-5-phosphate isomerase deficiency	0.425411863233137	-0.854697489361926	15	2	0.021505376344086	93	978	2539,5226	G6PD,PGD
SMP00520	Transaldolase deficiency	0.425411863233137	-0.854697489361926	15	2	0.021505376344086	93	978	2539,5226	G6PD,PGD
SMP00478	Nucleotide Excision Repair 	0.451819281248415	-0.7944729993462	6	1	0.010752688172043	93	978	25885	POLR1A
SMP00343	Intracellular Signalling Through PGD2 receptor and Prostaglandin D2	0.451819281248415	-0.7944729993462	6	1	0.010752688172043	93	978	5567	PRKACB
SMP00308	Dopamine Activation of Neurological Reward System	0.451819281248415	-0.7944729993462	6	1	0.010752688172043	93	978	5567	PRKACB
SMP00004	Glycine and Serine Metabolism	0.456513069600629	-0.784137949344615	26	3	0.032258064516129	93	978	6472,2617,29968	SHMT2,GARS,PSAT1
SMP00484	Dimethylglycine Dehydrogenase Deficiency	0.456513069600629	-0.784137949344615	26	3	0.032258064516129	93	978	6472,2617,29968	SHMT2,GARS,PSAT1
SMP00244	Sarcosinemia	0.456513069600629	-0.784137949344615	26	3	0.032258064516129	93	978	6472,2617,29968	SHMT2,GARS,PSAT1
SMP00242	Dimethylglycine Dehydrogenase Deficiency	0.456513069600629	-0.784137949344615	26	3	0.032258064516129	93	978	6472,2617,29968	SHMT2,GARS,PSAT1
SMP00223	Non Ketotic Hyperglycinemia	0.456513069600629	-0.784137949344615	26	3	0.032258064516129	93	978	6472,2617,29968	SHMT2,GARS,PSAT1
SMP00179	Dihydropyrimidine Dehydrogenase Deficiency (DHPD)	0.456513069600629	-0.784137949344615	26	3	0.032258064516129	93	978	6472,2617,29968	SHMT2,GARS,PSAT1
SMP00721	3-Phosphoglycerate dehydrogenase deficiency	0.456513069600629	-0.784137949344615	26	3	0.032258064516129	93	978	6472,2617,29968	SHMT2,GARS,PSAT1
SMP00485	Hyperglycinemia- non-ketotic	0.456513069600629	-0.784137949344615	26	3	0.032258064516129	93	978	6472,2617,29968	SHMT2,GARS,PSAT1
SMP00652	Mycophenolic Acid Metabolism Pathway	0.459205310580863	-0.778257869189858	16	2	0.021505376344086	93	978	1244,3615	ABCC2,IMPDH2
SMP00320	Intracellular Signalling Through Adenosine Receptor A2a and Adenosine	0.496434531646968	-0.700303663915301	38	4	0.043010752688172	93	978	5906,673,5567,3551	RAP1A,BRAF,PRKACB,IKBKB
SMP00321	Intracellular Signalling Through Adenosine Receptor A2b and Adenosine	0.496434531646968	-0.700303663915301	38	4	0.043010752688172	93	978	5906,673,5567,3551	RAP1A,BRAF,PRKACB,IKBKB
SMP00054	Fatty Acid Elongation In Mitochondria	0.504268671006032	-0.684646075553126	7	1	0.010752688172043	93	978	3028	HSD17B10
SMP00449	Ethanol Degradation	0.504268671006032	-0.684646075553126	7	1	0.010752688172043	93	978	847	CAT
SMP00434	Paclitaxel Action Pathway	0.504268671006032	-0.684646075553126	7	1	0.010752688172043	93	978	1244	ABCC2
SMP00322	Vasopressin Regulation of Water Homeostasis	0.504268671006032	-0.684646075553126	7	1	0.010752688172043	93	978	5567	PRKACB
SMP00544	Long-chain-3-hydroxyacyl-coa dehydrogenase deficiency (LCHAD)	0.504268671006032	-0.684646075553126	7	1	0.010752688172043	93	978	3028	HSD17B10
SMP00637	Tramadol Metabolism Pathway	0.504268671006032	-0.684646075553126	7	1	0.010752688172043	93	978	1244	ABCC2
SMP00041	Sulfate/Sulfite Metabolism	0.504268671006032	-0.684646075553126	7	1	0.010752688172043	93	978	50515	CHST11
SMP00435	Docetaxel Action Pathway	0.504268671006032	-0.684646075553126	7	1	0.010752688172043	93	978	1244	ABCC2
SMP00532	Sulfite oxidase deficiency	0.504268671006032	-0.684646075553126	7	1	0.010752688172043	93	978	50515	CHST11
SMP00725	Fructose intolerance- hereditary	0.523234596787036	-0.647725355667848	18	2	0.021505376344086	93	978	2762,7264	GMDS,TSTA3
SMP00442	Etoposide Action Pathway	0.523234596787036	-0.647725355667848	18	2	0.021505376344086	93	978	8714,3309	ABCC3,HSPA5
SMP00561	Fructosuria	0.523234596787036	-0.647725355667848	18	2	0.021505376344086	93	978	2762,7264	GMDS,TSTA3
SMP00064	Fructose and Mannose Degradation	0.523234596787036	-0.647725355667848	18	2	0.021505376344086	93	978	2762,7264	GMDS,TSTA3
SMP00601	Etoposide Metabolism Pathway	0.523234596787036	-0.647725355667848	18	2	0.021505376344086	93	978	8714,3309	ABCC3,HSPA5
SMP00030	Oxidation of Branched Chain Fatty Acids	0.551748602620277	-0.59466276648053	8	1	0.010752688172043	93	978	788	SLC25A20
SMP00481	Mitochondrial Beta-Oxidation of Medium Chain Saturated Fatty Acids	0.551748602620277	-0.59466276648053	8	1	0.010752688172043	93	978	788	SLC25A20
SMP00480	Mitochondrial Beta-Oxidation of Short Chain Saturated Fatty Acids	0.551748602620277	-0.59466276648053	8	1	0.010752688172043	93	978	3028	HSD17B10
SMP00568	Short-chain 3-hydroxyacyl-CoA dehydrogenase deficiency (SCHAD)	0.551748602620277	-0.59466276648053	8	1	0.010752688172043	93	978	3028	HSD17B10
SMP00354	Intracellular Signalling Through Prostacyclin Receptor and Prostacyclin	0.551748602620277	-0.59466276648053	8	1	0.010752688172043	93	978	5567	PRKACB
SMP00522	3-hydroxyisobutyric aciduria	0.555976220984731	-0.587029753659206	30	3	0.032258064516129	93	978	26275,5095,3028	HIBCH,PCCA,HSD17B10
SMP00524	Isovaleric acidemia	0.555976220984731	-0.587029753659206	30	3	0.032258064516129	93	978	26275,5095,3028	HIBCH,PCCA,HSD17B10
SMP00523	Isobutyryl-coa dehydrogenase deficiency	0.555976220984731	-0.587029753659206	30	3	0.032258064516129	93	978	26275,5095,3028	HIBCH,PCCA,HSD17B10
SMP00237	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	0.555976220984731	-0.587029753659206	30	3	0.032258064516129	93	978	26275,5095,3028	HIBCH,PCCA,HSD17B10
SMP00238	Isovaleric Aciduria	0.555976220984731	-0.587029753659206	30	3	0.032258064516129	93	978	26275,5095,3028	HIBCH,PCCA,HSD17B10
SMP00199	Maple Syrup Urine Disease	0.555976220984731	-0.587029753659206	30	3	0.032258064516129	93	978	26275,5095,3028	HIBCH,PCCA,HSD17B10
SMP00521	3-hydroxyisobutyric acid dehydrogenase deficiency	0.555976220984731	-0.587029753659206	30	3	0.032258064516129	93	978	26275,5095,3028	HIBCH,PCCA,HSD17B10
SMP00236	Propionic Acidemia	0.555976220984731	-0.587029753659206	30	3	0.032258064516129	93	978	26275,5095,3028	HIBCH,PCCA,HSD17B10
SMP00200	Methylmalonic Aciduria	0.555976220984731	-0.587029753659206	30	3	0.032258064516129	93	978	26275,5095,3028	HIBCH,PCCA,HSD17B10
SMP00384	Methylmalonate Semialdehyde Dehydrogenase Deficiency	0.555976220984731	-0.587029753659206	30	3	0.032258064516129	93	978	26275,5095,3028	HIBCH,PCCA,HSD17B10
SMP00140	3-Methylglutaconic Aciduria Type III	0.555976220984731	-0.587029753659206	30	3	0.032258064516129	93	978	26275,5095,3028	HIBCH,PCCA,HSD17B10
SMP00139	3-Methylglutaconic Aciduria Type I	0.555976220984731	-0.587029753659206	30	3	0.032258064516129	93	978	26275,5095,3028	HIBCH,PCCA,HSD17B10
SMP00032	Valine- Leucine and Isoleucine Degradation	0.555976220984731	-0.587029753659206	30	3	0.032258064516129	93	978	26275,5095,3028	HIBCH,PCCA,HSD17B10
SMP00173	Beta-Ketothiolase Deficiency	0.555976220984731	-0.587029753659206	30	3	0.032258064516129	93	978	26275,5095,3028	HIBCH,PCCA,HSD17B10
SMP00141	3-Methylglutaconic Aciduria Type IV	0.555976220984731	-0.587029753659206	30	3	0.032258064516129	93	978	26275,5095,3028	HIBCH,PCCA,HSD17B10
SMP00137	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	0.555976220984731	-0.587029753659206	30	3	0.032258064516129	93	978	26275,5095,3028	HIBCH,PCCA,HSD17B10
SMP00138	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	0.555976220984731	-0.587029753659206	30	3	0.032258064516129	93	978	26275,5095,3028	HIBCH,PCCA,HSD17B10
SMP00335	Intracellular Signalling Through Histamine H2 Receptor and Histamine	0.594725282988962	-0.519655689319298	9	1	0.010752688172043	93	978	5567	PRKACB
SMP00716	Thyroid hormone synthesis	0.594725282988962	-0.519655689319298	9	1	0.010752688172043	93	978	6528	SLC5A5
SMP00499	Beta-mercaptolactate-cysteine disulfiduria	0.594725282988962	-0.519655689319298	9	1	0.010752688172043	93	978	833	CARS
SMP00333	Intracellular Signalling Through FSH Receptor and Follicle Stimulating Hormone	0.594725282988962	-0.519655689319298	9	1	0.010752688172043	93	978	5567	PRKACB
SMP00013	Cysteine Metabolism	0.594725282988962	-0.519655689319298	9	1	0.010752688172043	93	978	833	CARS
SMP00452	Threonine and 2-Oxobutanoate Degradation	0.594725282988962	-0.519655689319298	9	1	0.010752688172043	93	978	5095	PCCA
SMP00722	Cystinosis- ocular nonnephropathic	0.594725282988962	-0.519655689319298	9	1	0.010752688172043	93	978	833	CARS
SMP00312	Excitatory Neural Signalling Through 5-HTR 6 and Serotonin 	0.594725282988962	-0.519655689319298	9	1	0.010752688172043	93	978	5567	PRKACB
SMP00309	Excitatory Neural Signalling Through 5-HTR 4 and Serotonin	0.594725282988962	-0.519655689319298	9	1	0.010752688172043	93	978	5567	PRKACB
SMP00548	Mitochondrial complex II deficiency	0.609454587346318	-0.495190840882091	21	2	0.021505376344086	93	978	8802,51660	SUCLG1,MPC1
SMP00011	Inositol Metabolism	0.609454587346318	-0.495190840882091	21	2	0.021505376344086	93	978	3628,30849	INPP1,PIK3R4
SMP00057	Citric Acid Cycle	0.609454587346318	-0.495190840882091	21	2	0.021505376344086	93	978	8802,51660	SUCLG1,MPC1
SMP00433	Irinotecan Action Pathway	0.609454587346318	-0.495190840882091	21	2	0.021505376344086	93	978	1244,3309	ABCC2,HSPA5
SMP00600	Irinotecan Metabolism Pathway	0.609454587346318	-0.495190840882091	21	2	0.021505376344086	93	978	1244,3309	ABCC2,HSPA5
SMP00551	Pyruvate dehydrogenase deficiency (E2)	0.609454587346318	-0.495190840882091	21	2	0.021505376344086	93	978	8802,51660	SUCLG1,MPC1
SMP00546	Congenital lactic acidosis	0.609454587346318	-0.495190840882091	21	2	0.021505376344086	93	978	8802,51660	SUCLG1,MPC1
SMP00549	2-ketoglutarate dehydrogenase complex deficiency	0.609454587346318	-0.495190840882091	21	2	0.021505376344086	93	978	8802,51660	SUCLG1,MPC1
SMP00547	Fumarase deficiency	0.609454587346318	-0.495190840882091	21	2	0.021505376344086	93	978	8802,51660	SUCLG1,MPC1
SMP00550	Pyruvate dehydrogenase deficiency (E3)	0.609454587346318	-0.495190840882091	21	2	0.021505376344086	93	978	8802,51660	SUCLG1,MPC1
SMP00338	Intracellular Signalling Through LHCGR Receptor and Luteinizing Hormone/Choriogonadotropin	0.633621618059755	-0.456303319651482	10	1	0.010752688172043	93	978	5567	PRKACB
SMP00128	Gluconeogenesis	0.635474670795409	-0.453383046274547	22	2	0.021505376344086	93	978	51660,3099	MPC1,HK2
SMP00581	Glycogenosis- Type IA. Von gierke disease	0.635474670795409	-0.453383046274547	22	2	0.021505376344086	93	978	51660,3099	MPC1,HK2
SMP00574	Glycogenosis- Type IC	0.635474670795409	-0.453383046274547	22	2	0.021505376344086	93	978	51660,3099	MPC1,HK2
SMP00563	Triosephosphate isomerase	0.635474670795409	-0.453383046274547	22	2	0.021505376344086	93	978	51660,3099	MPC1,HK2
SMP00562	Fructose-1-6-diphosphatase deficiency	0.635474670795409	-0.453383046274547	22	2	0.021505376344086	93	978	51660,3099	MPC1,HK2
SMP00374	Glycogen Storage Disease Type 1A (GSD1A) or Von Gierke Disease	0.635474670795409	-0.453383046274547	22	2	0.021505376344086	93	978	51660,3099	MPC1,HK2
SMP00560	Phosphoenolpyruvate carboxykinase deficiency 1 (PEPCK1)	0.635474670795409	-0.453383046274547	22	2	0.021505376344086	93	978	51660,3099	MPC1,HK2
SMP00573	Glycogenosis- Type IB	0.635474670795409	-0.453383046274547	22	2	0.021505376344086	93	978	51660,3099	MPC1,HK2
SMP00306	Pindolol Action Pathway	0.647912432302755	-0.433999727096719	57	5	0.0537634408602151	93	978	6262,7134,7168,23236,8912	RYR2,TNNC1,TPM1,PLCB1,CACNA1H
SMP00323	Quinidine Action Pathway	0.647912432302755	-0.433999727096719	57	5	0.0537634408602151	93	978	6262,7134,7168,23236,8912	RYR2,TNNC1,TPM1,PLCB1,CACNA1H
SMP00660	Sotalol Action Pathway	0.647912432302755	-0.433999727096719	57	5	0.0537634408602151	93	978	6262,7134,7168,23236,8912	RYR2,TNNC1,TPM1,PLCB1,CACNA1H
SMP00379	Nifedipine Action Pathway	0.647912432302755	-0.433999727096719	57	5	0.0537634408602151	93	978	6262,7134,7168,23236,8912	RYR2,TNNC1,TPM1,PLCB1,CACNA1H
SMP00325	Disopyramide Action Pathway	0.647912432302755	-0.433999727096719	57	5	0.0537634408602151	93	978	6262,7134,7168,23236,8912	RYR2,TNNC1,TPM1,PLCB1,CACNA1H
SMP00669	Practolol Action Pathway	0.647912432302755	-0.433999727096719	57	5	0.0537634408602151	93	978	6262,7134,7168,23236,8912	RYR2,TNNC1,TPM1,PLCB1,CACNA1H
SMP00667	Metipranolol Action Pathway	0.647912432302755	-0.433999727096719	57	5	0.0537634408602151	93	978	6262,7134,7168,23236,8912	RYR2,TNNC1,TPM1,PLCB1,CACNA1H
SMP00380	Nimodipine Action Pathway	0.647912432302755	-0.433999727096719	57	5	0.0537634408602151	93	978	6262,7134,7168,23236,8912	RYR2,TNNC1,TPM1,PLCB1,CACNA1H
SMP00381	Nisoldipine Action Pathway	0.647912432302755	-0.433999727096719	57	5	0.0537634408602151	93	978	6262,7134,7168,23236,8912	RYR2,TNNC1,TPM1,PLCB1,CACNA1H
SMP00659	Timolol Action Pathway	0.647912432302755	-0.433999727096719	57	5	0.0537634408602151	93	978	6262,7134,7168,23236,8912	RYR2,TNNC1,TPM1,PLCB1,CACNA1H
SMP00661	Epinephrine Action Pathway	0.647912432302755	-0.433999727096719	57	5	0.0537634408602151	93	978	6262,7134,7168,23236,8912	RYR2,TNNC1,TPM1,PLCB1,CACNA1H
SMP00324	Procainamide (Antiarrhythmic) Action Pathway	0.647912432302755	-0.433999727096719	57	5	0.0537634408602151	93	978	6262,7134,7168,23236,8912	RYR2,TNNC1,TPM1,PLCB1,CACNA1H
SMP00366	Nebivolol Action Pathway	0.647912432302755	-0.433999727096719	57	5	0.0537634408602151	93	978	6262,7134,7168,23236,8912	RYR2,TNNC1,TPM1,PLCB1,CACNA1H
SMP00377	Felodipine Action Pathway	0.647912432302755	-0.433999727096719	57	5	0.0537634408602151	93	978	6262,7134,7168,23236,8912	RYR2,TNNC1,TPM1,PLCB1,CACNA1H
SMP00296	Acebutolol Action Pathway	0.647912432302755	-0.433999727096719	57	5	0.0537634408602151	93	978	6262,7134,7168,23236,8912	RYR2,TNNC1,TPM1,PLCB1,CACNA1H
SMP00305	Penbutolol Action Pathway	0.647912432302755	-0.433999727096719	57	5	0.0537634408602151	93	978	6262,7134,7168,23236,8912	RYR2,TNNC1,TPM1,PLCB1,CACNA1H
SMP00663	Isoprenaline Action Pathway	0.647912432302755	-0.433999727096719	57	5	0.0537634408602151	93	978	6262,7134,7168,23236,8912	RYR2,TNNC1,TPM1,PLCB1,CACNA1H
SMP00658	Carteolol Action Pathway	0.647912432302755	-0.433999727096719	57	5	0.0537634408602151	93	978	6262,7134,7168,23236,8912	RYR2,TNNC1,TPM1,PLCB1,CACNA1H
SMP00657	Bopindolol Action Pathway	0.647912432302755	-0.433999727096719	57	5	0.0537634408602151	93	978	6262,7134,7168,23236,8912	RYR2,TNNC1,TPM1,PLCB1,CACNA1H
SMP00664	Arbutamine Action Pathway	0.647912432302755	-0.433999727096719	57	5	0.0537634408602151	93	978	6262,7134,7168,23236,8912	RYR2,TNNC1,TPM1,PLCB1,CACNA1H
SMP00588	Muscle/Heart Contraction	0.647912432302755	-0.433999727096719	57	5	0.0537634408602151	93	978	6262,7134,7168,23236,8912	RYR2,TNNC1,TPM1,PLCB1,CACNA1H
SMP00298	Atenolol Action Pathway	0.647912432302755	-0.433999727096719	57	5	0.0537634408602151	93	978	6262,7134,7168,23236,8912	RYR2,TNNC1,TPM1,PLCB1,CACNA1H
SMP00304	Oxprenolol Action Pathway	0.647912432302755	-0.433999727096719	57	5	0.0537634408602151	93	978	6262,7134,7168,23236,8912	RYR2,TNNC1,TPM1,PLCB1,CACNA1H
SMP00332	Ibutilide Action Pathway	0.647912432302755	-0.433999727096719	57	5	0.0537634408602151	93	978	6262,7134,7168,23236,8912	RYR2,TNNC1,TPM1,PLCB1,CACNA1H
SMP00665	Amiodarone Action Pathway	0.647912432302755	-0.433999727096719	57	5	0.0537634408602151	93	978	6262,7134,7168,23236,8912	RYR2,TNNC1,TPM1,PLCB1,CACNA1H
SMP00378	Isradipine Action Pathway	0.647912432302755	-0.433999727096719	57	5	0.0537634408602151	93	978	6262,7134,7168,23236,8912	RYR2,TNNC1,TPM1,PLCB1,CACNA1H
SMP00670	Bupranolol Action Pathway	0.647912432302755	-0.433999727096719	57	5	0.0537634408602151	93	978	6262,7134,7168,23236,8912	RYR2,TNNC1,TPM1,PLCB1,CACNA1H
SMP00303	Nadolol Action Pathway	0.647912432302755	-0.433999727096719	57	5	0.0537634408602151	93	978	6262,7134,7168,23236,8912	RYR2,TNNC1,TPM1,PLCB1,CACNA1H
SMP00297	Alprenolol Action Pathway	0.647912432302755	-0.433999727096719	57	5	0.0537634408602151	93	978	6262,7134,7168,23236,8912	RYR2,TNNC1,TPM1,PLCB1,CACNA1H
SMP00331	Flecainide Action Pathway	0.647912432302755	-0.433999727096719	57	5	0.0537634408602151	93	978	6262,7134,7168,23236,8912	RYR2,TNNC1,TPM1,PLCB1,CACNA1H
SMP00359	Diltiazem Action Pathway	0.647912432302755	-0.433999727096719	57	5	0.0537634408602151	93	978	6262,7134,7168,23236,8912	RYR2,TNNC1,TPM1,PLCB1,CACNA1H
SMP00375	Verapamil Action Pathway	0.647912432302755	-0.433999727096719	57	5	0.0537634408602151	93	978	6262,7134,7168,23236,8912	RYR2,TNNC1,TPM1,PLCB1,CACNA1H
SMP00382	Nitrendipine Action Pathway	0.647912432302755	-0.433999727096719	57	5	0.0537634408602151	93	978	6262,7134,7168,23236,8912	RYR2,TNNC1,TPM1,PLCB1,CACNA1H
SMP00662	Dobutamine Action Pathway	0.647912432302755	-0.433999727096719	57	5	0.0537634408602151	93	978	6262,7134,7168,23236,8912	RYR2,TNNC1,TPM1,PLCB1,CACNA1H
SMP00329	Mexiletine Action Pathway	0.647912432302755	-0.433999727096719	57	5	0.0537634408602151	93	978	6262,7134,7168,23236,8912	RYR2,TNNC1,TPM1,PLCB1,CACNA1H
SMP00302	Metoprolol Action Pathway	0.647912432302755	-0.433999727096719	57	5	0.0537634408602151	93	978	6262,7134,7168,23236,8912	RYR2,TNNC1,TPM1,PLCB1,CACNA1H
SMP00300	Bisoprolol Action Pathway	0.647912432302755	-0.433999727096719	57	5	0.0537634408602151	93	978	6262,7134,7168,23236,8912	RYR2,TNNC1,TPM1,PLCB1,CACNA1H
SMP00376	Amlodipine Action Pathway	0.647912432302755	-0.433999727096719	57	5	0.0537634408602151	93	978	6262,7134,7168,23236,8912	RYR2,TNNC1,TPM1,PLCB1,CACNA1H
SMP00301	Esmolol Action Pathway	0.647912432302755	-0.433999727096719	57	5	0.0537634408602151	93	978	6262,7134,7168,23236,8912	RYR2,TNNC1,TPM1,PLCB1,CACNA1H
SMP00299	Betaxolol Action Pathway	0.647912432302755	-0.433999727096719	57	5	0.0537634408602151	93	978	6262,7134,7168,23236,8912	RYR2,TNNC1,TPM1,PLCB1,CACNA1H
SMP00330	Tocainide Action Pathway	0.647912432302755	-0.433999727096719	57	5	0.0537634408602151	93	978	6262,7134,7168,23236,8912	RYR2,TNNC1,TPM1,PLCB1,CACNA1H
SMP00307	Propranolol Action Pathway	0.647912432302755	-0.433999727096719	57	5	0.0537634408602151	93	978	6262,7134,7168,23236,8912	RYR2,TNNC1,TPM1,PLCB1,CACNA1H
SMP00326	Fosphenytoin (Antiarrhythmic) Action Pathway	0.647912432302755	-0.433999727096719	57	5	0.0537634408602151	93	978	6262,7134,7168,23236,8912	RYR2,TNNC1,TPM1,PLCB1,CACNA1H
SMP00666	Levobunolol Action Pathway	0.647912432302755	-0.433999727096719	57	5	0.0537634408602151	93	978	6262,7134,7168,23236,8912	RYR2,TNNC1,TPM1,PLCB1,CACNA1H
SMP00668	Bevantolol Action Pathway	0.647912432302755	-0.433999727096719	57	5	0.0537634408602151	93	978	6262,7134,7168,23236,8912	RYR2,TNNC1,TPM1,PLCB1,CACNA1H
SMP00368	Labetalol Action Pathway	0.663715727037041	-0.409901343108231	58	5	0.0537634408602151	93	978	6262,7134,7168,23236,8912	RYR2,TNNC1,TPM1,PLCB1,CACNA1H
SMP00367	Carvedilol Action Pathway	0.663715727037041	-0.409901343108231	58	5	0.0537634408602151	93	978	6262,7134,7168,23236,8912	RYR2,TNNC1,TPM1,PLCB1,CACNA1H
SMP00635	Valproic Acid Metabolism Pathway	0.668821194012033	-0.402238528102457	11	1	0.010752688172043	93	978	3028	HSD17B10
SMP00370	Tyrosinemia Type 3 (TYRO3)	0.668821194012033	-0.402238528102457	11	1	0.010752688172043	93	978	8565	YARS
SMP00008	Phenylalanine and Tyrosine Metabolism	0.668821194012033	-0.402238528102457	11	1	0.010752688172043	93	978	8565	YARS
SMP00009	Ammonia Recycling	0.668821194012033	-0.402238528102457	11	1	0.010752688172043	93	978	440	ASNS
SMP00206	Phenylketonuria	0.668821194012033	-0.402238528102457	11	1	0.010752688172043	93	978	8565	YARS
SMP00369	Tyrosinemia Type 2 (or Richner-Hanhart syndrome)	0.668821194012033	-0.402238528102457	11	1	0.010752688172043	93	978	8565	YARS
SMP00328	Lidocaine (Antiarrhythmic) Action Pathway	0.67906604488525	-0.387036888281416	59	5	0.0537634408602151	93	978	6262,7134,7168,23236,8912	RYR2,TNNC1,TPM1,PLCB1,CACNA1H
SMP00002	Carbamoyl Phosphate Synthetase Deficiency	0.729489198067435	-0.315410718438816	13	1	0.010752688172043	93	978	8604	SLC25A12
SMP00003	Argininosuccinic Aciduria	0.729489198067435	-0.315410718438816	13	1	0.010752688172043	93	978	8604	SLC25A12
SMP00205	Ornithine Transcarbamylase Deficiency (OTC Deficiency)	0.729489198067435	-0.315410718438816	13	1	0.010752688172043	93	978	8604	SLC25A12
SMP00357	Argininemia	0.729489198067435	-0.315410718438816	13	1	0.010752688172043	93	978	8604	SLC25A12
SMP00001	Citrullinemia Type I	0.729489198067435	-0.315410718438816	13	1	0.010752688172043	93	978	8604	SLC25A12
SMP00059	Urea Cycle	0.729489198067435	-0.315410718438816	13	1	0.010752688172043	93	978	8604	SLC25A12
SMP00185	Glutaric Aciduria Type I	0.755559151000746	-0.280297206488022	14	1	0.010752688172043	93	978	1374	CPT1A
SMP00540	Very-long-chain acyl coa dehydrogenase deficiency (VLCAD)	0.755559151000746	-0.280297206488022	14	1	0.010752688172043	93	978	1374	CPT1A
SMP00545	Trifunctional protein deficiency	0.755559151000746	-0.280297206488022	14	1	0.010752688172043	93	978	1374	CPT1A
SMP00648	Sorafenib Metabolism Pathway	0.755559151000746	-0.280297206488022	14	1	0.010752688172043	93	978	3309	HSPA5
SMP00542	Medium chain acyl-coa dehydrogenase deficiency (MCAD)	0.755559151000746	-0.280297206488022	14	1	0.010752688172043	93	978	1374	CPT1A
SMP00235	Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency)	0.755559151000746	-0.280297206488022	14	1	0.010752688172043	93	978	1374	CPT1A
SMP00181	Ethylmalonic Encephalopathy	0.755559151000746	-0.280297206488022	14	1	0.010752688172043	93	978	1374	CPT1A
SMP00462	Inositol Phosphate Metabolism	0.755559151000746	-0.280297206488022	14	1	0.010752688172043	93	978	3628	INPP1
SMP00538	Carnitine palmitoyl transferase deficiency (I)	0.755559151000746	-0.280297206488022	14	1	0.010752688172043	93	978	1374	CPT1A
SMP00541	Carnitine palmitoyl transferase deficiency (II)	0.755559151000746	-0.280297206488022	14	1	0.010752688172043	93	978	1374	CPT1A
SMP00051	Fatty acid Metabolism	0.755559151000746	-0.280297206488022	14	1	0.010752688172043	93	978	1374	CPT1A
SMP00539	Long chain acyl-CoA dehydrogenase deficiency (LCAD)	0.755559151000746	-0.280297206488022	14	1	0.010752688172043	93	978	1374	CPT1A
SMP00327	Phenytoin (Antiarrhythmic) Action Pathway	0.76282678347243	-0.270724293821382	77	6	0.0645161290322581	93	978	6262,7134,7168,23236,3309,8912	RYR2,TNNC1,TPM1,PLCB1,HSPA5,CACNA1H
SMP00706	Tenoxicam Action Pathway	0.764078048800997	-0.269085336916914	28	2	0.021505376344086	93	978	2678,6916	GGT1,TBXAS1
SMP00693	Antrafenine Action Pathway	0.764078048800997	-0.269085336916914	28	2	0.021505376344086	93	978	2678,6916	GGT1,TBXAS1
SMP00102	Bromfenac Action Pathway	0.764078048800997	-0.269085336916914	28	2	0.021505376344086	93	978	2678,6916	GGT1,TBXAS1
SMP00699	Lumiracoxib Action Pathway	0.764078048800997	-0.269085336916914	28	2	0.021505376344086	93	978	2678,6916	GGT1,TBXAS1
SMP00098	Ketorolac Action Pathway	0.764078048800997	-0.269085336916914	28	2	0.021505376344086	93	978	2678,6916	GGT1,TBXAS1
SMP00106	Meloxicam Action Pathway	0.764078048800997	-0.269085336916914	28	2	0.021505376344086	93	978	2678,6916	GGT1,TBXAS1
SMP00707	Salsalate Action Pathway	0.764078048800997	-0.269085336916914	28	2	0.021505376344086	93	978	2678,6916	GGT1,TBXAS1
SMP00085	Ketoprofen Action Pathway	0.764078048800997	-0.269085336916914	28	2	0.021505376344086	93	978	2678,6916	GGT1,TBXAS1
SMP00692	Antipyrine Action Pathway	0.764078048800997	-0.269085336916914	28	2	0.021505376344086	93	978	2678,6916	GGT1,TBXAS1
SMP00353	Leukotriene C4 Synthesis Deficiency	0.764078048800997	-0.269085336916914	28	2	0.021505376344086	93	978	2678,6916	GGT1,TBXAS1
SMP00700	Lornoxicam Action Pathway	0.764078048800997	-0.269085336916914	28	2	0.021505376344086	93	978	2678,6916	GGT1,TBXAS1
SMP00701	Phenylbutazone Action Pathway	0.764078048800997	-0.269085336916914	28	2	0.021505376344086	93	978	2678,6916	GGT1,TBXAS1
SMP00640	Acetaminophen Metabolism Pathway	0.764078048800997	-0.269085336916914	28	2	0.021505376344086	93	978	10257,3309	ABCC4,HSPA5
SMP00094	Sulindac Action Pathway	0.764078048800997	-0.269085336916914	28	2	0.021505376344086	93	978	2678,6916	GGT1,TBXAS1
SMP00114	Nabumetone Action Pathway	0.764078048800997	-0.269085336916914	28	2	0.021505376344086	93	978	2678,6916	GGT1,TBXAS1
SMP00109	Mefenamic Acid Action Pathway	0.764078048800997	-0.269085336916914	28	2	0.021505376344086	93	978	2678,6916	GGT1,TBXAS1
SMP00113	Oxaprozin Action Pathway	0.764078048800997	-0.269085336916914	28	2	0.021505376344086	93	978	2678,6916	GGT1,TBXAS1
SMP00702	Nepafenac Action Pathway	0.764078048800997	-0.269085336916914	28	2	0.021505376344086	93	978	2678,6916	GGT1,TBXAS1
SMP00698	Magnesium salicylate Action Pathway	0.764078048800997	-0.269085336916914	28	2	0.021505376344086	93	978	2678,6916	GGT1,TBXAS1
SMP00289	Diflunisal Action Pathway	0.764078048800997	-0.269085336916914	28	2	0.021505376344086	93	978	2678,6916	GGT1,TBXAS1
SMP00708	Salicylate-sodium Action Pathway	0.764078048800997	-0.269085336916914	28	2	0.021505376344086	93	978	2678,6916	GGT1,TBXAS1
SMP00077	Piroxicam Action Pathway	0.764078048800997	-0.269085336916914	28	2	0.021505376344086	93	978	2678,6916	GGT1,TBXAS1
SMP00083	Acetylsalicylic Acid Action Pathway	0.764078048800997	-0.269085336916914	28	2	0.021505376344086	93	978	2678,6916	GGT1,TBXAS1
SMP00710	Acetaminophen  Action Pathway	0.764078048800997	-0.269085336916914	28	2	0.021505376344086	93	978	2678,6916	GGT1,TBXAS1
SMP00697	Flurbiprofen Action Pathway	0.764078048800997	-0.269085336916914	28	2	0.021505376344086	93	978	2678,6916	GGT1,TBXAS1
SMP00084	Etodolac Action Pathway	0.764078048800997	-0.269085336916914	28	2	0.021505376344086	93	978	2678,6916	GGT1,TBXAS1
SMP00075	Arachidonic Acid Metabolism	0.764078048800997	-0.269085336916914	28	2	0.021505376344086	93	978	2678,6916	GGT1,TBXAS1
SMP00696	Fenoprofen Action Pathway	0.764078048800997	-0.269085336916914	28	2	0.021505376344086	93	978	2678,6916	GGT1,TBXAS1
SMP00703	Trisalicylate-choline Action Pathway	0.764078048800997	-0.269085336916914	28	2	0.021505376344086	93	978	2678,6916	GGT1,TBXAS1
SMP00709	Salicylic Acid Action Pathway	0.764078048800997	-0.269085336916914	28	2	0.021505376344086	93	978	2678,6916	GGT1,TBXAS1
SMP00093	Diclofenac Action Pathway	0.764078048800997	-0.269085336916914	28	2	0.021505376344086	93	978	2678,6916	GGT1,TBXAS1
SMP00695	Etoricoxib Action Pathway	0.764078048800997	-0.269085336916914	28	2	0.021505376344086	93	978	2678,6916	GGT1,TBXAS1
SMP00101	Suprofen Action Pathway	0.764078048800997	-0.269085336916914	28	2	0.021505376344086	93	978	2678,6916	GGT1,TBXAS1
SMP00704	Tolmetin Action Pathway	0.764078048800997	-0.269085336916914	28	2	0.021505376344086	93	978	2678,6916	GGT1,TBXAS1
SMP00694	Carprofen Action Pathway	0.764078048800997	-0.269085336916914	28	2	0.021505376344086	93	978	2678,6916	GGT1,TBXAS1
SMP00705	Tiaprofenic Acid Action Pathway	0.764078048800997	-0.269085336916914	28	2	0.021505376344086	93	978	2678,6916	GGT1,TBXAS1
SMP00087	Rofecoxib Action Pathway	0.764078048800997	-0.269085336916914	28	2	0.021505376344086	93	978	2678,6916	GGT1,TBXAS1
SMP00116	Valdecoxib Action Pathway	0.764078048800997	-0.269085336916914	28	2	0.021505376344086	93	978	2678,6916	GGT1,TBXAS1
SMP00120	Naproxen Action Pathway	0.764078048800997	-0.269085336916914	28	2	0.021505376344086	93	978	2678,6916	GGT1,TBXAS1
SMP00622	Morphine Metabolism Pathway	0.779141100128302	-0.249563119695311	15	1	0.010752688172043	93	978	3309	HSPA5
SMP00040	Glycolysis	0.779141100128302	-0.249563119695311	15	1	0.010752688172043	93	978	3099	HK2
SMP00531	Glycogenosis- Type VII. Tarui disease	0.779141100128302	-0.249563119695311	15	1	0.010752688172043	93	978	3099	HK2
SMP00572	Fanconi-bickel syndrome	0.779141100128302	-0.249563119695311	15	1	0.010752688172043	93	978	3099	HK2
SMP00104	Indomethacin Action Pathway	0.781262928247806	-0.246843529911253	29	2	0.021505376344086	93	978	2678,6916	GGT1,TBXAS1
SMP00555	Glycogenosis- Type VI. Hers disease	0.800470152766825	-0.222556032978381	16	1	0.010752688172043	93	978	3099	HK2
SMP00058	Starch and Sucrose Metabolism	0.800470152766825	-0.222556032978381	16	1	0.010752688172043	93	978	3099	HK2
SMP00557	Sucrase-isomaltase deficiency	0.800470152766825	-0.222556032978381	16	1	0.010752688172043	93	978	3099	HK2
SMP00556	Mucopolysaccharidosis VI. Sly syndrome	0.800470152766825	-0.222556032978381	16	1	0.010752688172043	93	978	3099	HK2
SMP00552	Glycogen synthetase deficiency	0.800470152766825	-0.222556032978381	16	1	0.010752688172043	93	978	3099	HK2
SMP00317	Familial Hypercholanemia (FHCA)	0.819759420743821	-0.198744371107714	17	1	0.010752688172043	93	978	80270	HSD3B7
SMP00316	Zellweger Syndrome	0.819759420743821	-0.198744371107714	17	1	0.010752688172043	93	978	80270	HSD3B7
SMP00315	Cerebrotendinous Xanthomatosis (CTX)	0.819759420743821	-0.198744371107714	17	1	0.010752688172043	93	978	80270	HSD3B7
SMP00314	Congenital Bile Acid Synthesis Defect Type II	0.819759420743821	-0.198744371107714	17	1	0.010752688172043	93	978	80270	HSD3B7
SMP00035	Bile Acid Biosynthesis	0.819759420743821	-0.198744371107714	17	1	0.010752688172043	93	978	80270	HSD3B7
SMP00650	Doxorubicin Metabolism Pathway	0.819759420743821	-0.198744371107714	17	1	0.010752688172043	93	978	1244	ABCC2
SMP00318	Congenital Bile Acid Synthesis Defect Type III	0.819759420743821	-0.198744371107714	17	1	0.010752688172043	93	978	80270	HSD3B7
SMP00720	27-Hydroxylase Deficiency	0.819759420743821	-0.198744371107714	17	1	0.010752688172043	93	978	80270	HSD3B7
SMP00086	Ibuprofen Action Pathway	0.843496612716633	-0.170199392752094	47	3	0.032258064516129	93	978	2678,3309,6916	GGT1,HSPA5,TBXAS1
SMP00096	Celecoxib Action Pathway	0.851795132291605	-0.160409236123576	34	2	0.021505376344086	93	978	2678,6916	GGT1,TBXAS1
SMP00355	Mitochondrial Electron Transport Chain	0.852973108135299	-0.159027258206295	19	1	0.010752688172043	93	978	517	ATP5G2
SMP00363	Ornithine Aminotransferase Deficiency (OAT Deficiency)	0.867231190456484	-0.142449682088746	20	1	0.010752688172043	93	978	2058	EPRS
SMP00506	Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome]	0.867231190456484	-0.142449682088746	20	1	0.010752688172043	93	978	2058	EPRS
SMP00507	L-arginine:glycine amidinotransferase deficiency	0.867231190456484	-0.142449682088746	20	1	0.010752688172043	93	978	2058	EPRS
SMP00505	Hyperornithinemia with gyrate atrophy (HOGA)	0.867231190456484	-0.142449682088746	20	1	0.010752688172043	93	978	2058	EPRS
SMP00362	Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency)	0.867231190456484	-0.142449682088746	20	1	0.010752688172043	93	978	2058	EPRS
SMP00504	Creatine deficiency- guanidinoacetate methyltransferase deficiency	0.867231190456484	-0.142449682088746	20	1	0.010752688172043	93	978	2058	EPRS
SMP00207	Prolidase Deficiency (PD)	0.867231190456484	-0.142449682088746	20	1	0.010752688172043	93	978	2058	EPRS
SMP00360	Hyperprolinemia Type II	0.867231190456484	-0.142449682088746	20	1	0.010752688172043	93	978	2058	EPRS
SMP00188	Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency)	0.867231190456484	-0.142449682088746	20	1	0.010752688172043	93	978	2058	EPRS
SMP00208	Prolinemia Type II	0.867231190456484	-0.142449682088746	20	1	0.010752688172043	93	978	2058	EPRS
SMP00361	Hyperprolinemia Type I	0.867231190456484	-0.142449682088746	20	1	0.010752688172043	93	978	2058	EPRS
SMP00020	Arginine and Proline Metabolism	0.867231190456484	-0.142449682088746	20	1	0.010752688172043	93	978	2058	EPRS
SMP00060	Pyruvate Metabolism	0.89176979917604	-0.114547252381211	22	1	0.010752688172043	93	978	4199	ME1
SMP00136	2-Hydroxyglutric Aciduria (D And L Form)	0.89176979917604	-0.114547252381211	22	1	0.010752688172043	93	978	790	CAD
SMP00567	Succinic semialdehyde dehydrogenase deficiency	0.89176979917604	-0.114547252381211	22	1	0.010752688172043	93	978	790	CAD
SMP00339	Hyperinsulinism-Hyperammonemia Syndrome	0.89176979917604	-0.114547252381211	22	1	0.010752688172043	93	978	790	CAD
SMP00334	Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency)	0.89176979917604	-0.114547252381211	22	1	0.010752688172043	93	978	4199	ME1
SMP00243	4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency	0.89176979917604	-0.114547252381211	22	1	0.010752688172043	93	978	790	CAD
SMP00196	Leigh Syndrome	0.89176979917604	-0.114547252381211	22	1	0.010752688172043	93	978	4199	ME1
SMP00590	Ibuprofen Metabolism Pathway	0.89176979917604	-0.114547252381211	22	1	0.010752688172043	93	978	3309	HSPA5
SMP00212	Pyruvate Dehydrogenase Complex Deficiency	0.89176979917604	-0.114547252381211	22	1	0.010752688172043	93	978	4199	ME1
SMP00385	Homocarnosinosis	0.89176979917604	-0.114547252381211	22	1	0.010752688172043	93	978	790	CAD
SMP00558	Primary hyperoxaluria II- PH2	0.89176979917604	-0.114547252381211	22	1	0.010752688172043	93	978	4199	ME1
SMP00072	Glutamate Metabolism	0.89176979917604	-0.114547252381211	22	1	0.010752688172043	93	978	790	CAD
SMP00559	Pyruvate kinase deficiency	0.89176979917604	-0.114547252381211	22	1	0.010752688172043	93	978	4199	ME1
SMP00219	UMP Synthase Deiciency (Orotic Aciduria)	0.902298469342597	-0.102809916378336	23	1	0.010752688172043	93	978	790	CAD
SMP00202	MNGIE (Mitochondrial Neurogastrointestinal Encephalopathy)	0.902298469342597	-0.102809916378336	23	1	0.010752688172043	93	978	790	CAD
SMP00172	Beta Ureidopropionase Deficiency	0.902298469342597	-0.102809916378336	23	1	0.010752688172043	93	978	790	CAD
SMP00046	Pyrimidine Metabolism	0.902298469342597	-0.102809916378336	23	1	0.010752688172043	93	978	790	CAD
SMP00178	Dihydropyrimidinase Deficiency	0.902298469342597	-0.102809916378336	23	1	0.010752688172043	93	978	790	CAD
SMP00429	Disulfiram Action Pathway	0.911812859242714	-0.092320508162615	24	1	0.010752688172043	93	978	847	CAT
SMP00078	Chlorothiazide Action Pathway	0.968542464573315	-0.0319629513829985	34	1	0.010752688172043	93	978	6520	SLC3A2
SMP00088	Bumetanide Action Pathway	0.968542464573315	-0.0319629513829985	34	1	0.010752688172043	93	978	6520	SLC3A2
SMP00115	Furosemide Action Pathway	0.968542464573315	-0.0319629513829985	34	1	0.010752688172043	93	978	6520	SLC3A2
SMP00105	Metolazone Action Pathway	0.968542464573315	-0.0319629513829985	34	1	0.010752688172043	93	978	6520	SLC3A2
SMP00197	Lysinuric Protein Intolerance	0.968542464573315	-0.0319629513829985	34	1	0.010752688172043	93	978	6520	SLC3A2
SMP00245	Glucose Transporter Defect (SGLT2)	0.968542464573315	-0.0319629513829985	34	1	0.010752688172043	93	978	6520	SLC3A2
SMP00090	Bendroflumethiazide Action Pathway	0.968542464573315	-0.0319629513829985	34	1	0.010752688172043	93	978	6520	SLC3A2
SMP00100	Hydrochlorothiazide Action Pathway	0.968542464573315	-0.0319629513829985	34	1	0.010752688172043	93	978	6520	SLC3A2
SMP00583	Blue diaper syndrome	0.968542464573315	-0.0319629513829985	34	1	0.010752688172043	93	978	6520	SLC3A2
SMP00135	Eplerenone Action Pathway	0.968542464573315	-0.0319629513829985	34	1	0.010752688172043	93	978	6520	SLC3A2
SMP00483	Kidney Function	0.968542464573315	-0.0319629513829985	34	1	0.010752688172043	93	978	6520	SLC3A2
SMP00081	Methyclothiazide Action Pathway	0.968542464573315	-0.0319629513829985	34	1	0.010752688172043	93	978	6520	SLC3A2
SMP00108	Hydroflumethiazide Action Pathway	0.968542464573315	-0.0319629513829985	34	1	0.010752688172043	93	978	6520	SLC3A2
SMP00723	Cystinuria	0.968542464573315	-0.0319629513829985	34	1	0.010752688172043	93	978	6520	SLC3A2
SMP00134	Spironolactone Action Pathway	0.968542464573315	-0.0319629513829985	34	1	0.010752688172043	93	978	6520	SLC3A2
SMP00118	Torsemide Action Pathway	0.968542464573315	-0.0319629513829985	34	1	0.010752688172043	93	978	6520	SLC3A2
SMP00189	Hartnup Disorder	0.968542464573315	-0.0319629513829985	34	1	0.010752688172043	93	978	6520	SLC3A2
SMP00133	Amiloride Action Pathway	0.968542464573315	-0.0319629513829985	34	1	0.010752688172043	93	978	6520	SLC3A2
SMP00184	Glucose Transporter Defect (SGLT2)	0.968542464573315	-0.0319629513829985	34	1	0.010752688172043	93	978	6520	SLC3A2
SMP00097	Ethacrynic Acid Action Pathway	0.968542464573315	-0.0319629513829985	34	1	0.010752688172043	93	978	6520	SLC3A2
SMP00091	Quinethazone Action Pathway	0.968542464573315	-0.0319629513829985	34	1	0.010752688172043	93	978	6520	SLC3A2
SMP00585	Lysinuric protein intolerance (LPI)	0.968542464573315	-0.0319629513829985	34	1	0.010752688172043	93	978	6520	SLC3A2
SMP00132	Triamterene Action Pathway	0.968542464573315	-0.0319629513829985	34	1	0.010752688172043	93	978	6520	SLC3A2
SMP00103	Cyclothiazide Action Pathway	0.968542464573315	-0.0319629513829985	34	1	0.010752688172043	93	978	6520	SLC3A2
SMP00110	Indapamide Action Pathway	0.968542464573315	-0.0319629513829985	34	1	0.010752688172043	93	978	6520	SLC3A2
SMP00193	Iminoglycinuria	0.968542464573315	-0.0319629513829985	34	1	0.010752688172043	93	978	6520	SLC3A2
SMP00121	Trichlormethiazide Action Pathway	0.968542464573315	-0.0319629513829985	34	1	0.010752688172043	93	978	6520	SLC3A2
SMP00080	Polythiazide Action Pathway	0.968542464573315	-0.0319629513829985	34	1	0.010752688172043	93	978	6520	SLC3A2
SMP00122	Chlorthalidone Action Pathway	0.968542464573315	-0.0319629513829985	34	1	0.010752688172043	93	978	6520	SLC3A2
SMP00336	Vitamin A Deficiency	0.971641564993798	-0.0287683028249421	35	1	0.010752688172043	93	978	3309	HSPA5
SMP00074	Retinol Metabolism	0.971641564993798	-0.0287683028249421	35	1	0.010752688172043	93	978	3309	HSPA5
SMP00406	Morphine Action Pathway	0.983145617857262	-0.0169980336338605	40	1	0.010752688172043	93	978	3309	HSPA5
SMP00455	Homocysteine Degradation	0.999999999997004	-2.99621091826019e-12	2	0	0	93	978
SMP00612	Esomeprazole Metabolism Pathway	0.999999999997004	-2.99621091826019e-12	2	0	0	93	978
SMP00616	Rabeprazole Metabolism Pathway	0.999999999997004	-2.99621091826019e-12	2	0	0	93	978
SMP00613	Omeprazole Metabolism Pathway	0.999999999997004	-2.99621091826019e-12	2	0	0	93	978
SMP00515	Homocystinuria- cystathionine beta-synthase deficiency	0.999999999997004	-2.99621091826019e-12	2	0	0	93	978
SMP00614	Lansoprazole Metabolism Pathway	0.999999999997004	-2.99621091826019e-12	2	0	0	93	978
SMP00615	Pantoprazole Metabolism Pathway	0.999999999997004	-2.99621091826019e-12	2	0	0	93	978
SMP00456	Fatty Acid Biosynthesis	0.999999999997004	-2.99621091826019e-12	2	0	0	93	978
SMP00514	Gamma-cystathionase deficiency (CTH)	0.999999999997004	-2.99621091826019e-12	2	0	0	93	978
SMP00153	Quinapril Action Pathway	0.999999999999667	-3.33202405554053e-13	4	0	0	93	978
SMP00623	Heroin Metabolism Pathway	0.999999999999667	-3.33202405554053e-13	4	0	0	93	978
SMP00165	Valsartan Action Pathway	0.999999999999667	-3.33202405554053e-13	4	0	0	93	978
SMP00618	Fosphenytoin (Antiarrhythmic) Metabolism Pathway	0.999999999999667	-3.33202405554053e-13	4	0	0	93	978
SMP00602	Teniposide Metabolism Pathway	0.999999999999667	-3.33202405554053e-13	4	0	0	93	978
SMP00150	Lisinopril Action Pathway	0.999999999999667	-3.33202405554053e-13	4	0	0	93	978
SMP00633	Felbamate Metabolism Pathway	0.999999999999667	-3.33202405554053e-13	4	0	0	93	978
SMP00164	Telmisartan Action Pathway	0.999999999999667	-3.33202405554053e-13	4	0	0	93	978
SMP00651	Artemether Metabolism Pathway	0.999999999999667	-3.33202405554053e-13	4	0	0	93	978
SMP00170	Aromatic L-Aminoacid Decarboxylase Deficiency	0.999999999999667	-3.33202405554053e-13	4	0	0	93	978
SMP00145	Benazepril Action Pathway	0.999999999999667	-3.33202405554053e-13	4	0	0	93	978
SMP00620	Lidocaine (Local Anaesthetic) Metabolism Pathway	0.999999999999667	-3.33202405554053e-13	4	0	0	93	978
SMP00443	Teniposide Action Pathway	0.999999999999667	-3.33202405554053e-13	4	0	0	93	978
SMP00733	Temocapril Action Pathway	0.999999999999667	-3.33202405554053e-13	4	0	0	93	978
SMP00621	Codeine Metabolism Pathway	0.999999999999667	-3.33202405554053e-13	4	0	0	93	978
SMP00450	Phytanic Acid Peroxisomal Oxidation	0.999999999999667	-3.33202405554053e-13	4	0	0	93	978
SMP00152	Perindopril Action Pathway	0.999999999999667	-3.33202405554053e-13	4	0	0	93	978
SMP00012	Catecholamine Biosynthesis	0.999999999999667	-3.33202405554053e-13	4	0	0	93	978
SMP00149	Fosinopril Action Pathway	0.999999999999667	-3.33202405554053e-13	4	0	0	93	978
SMP00065	Ubiquinone Biosynthesis	0.999999999999667	-3.33202405554053e-13	4	0	0	93	978
SMP00163	Olmesartan Action Pathway	0.999999999999667	-3.33202405554053e-13	4	0	0	93	978
SMP00154	Ramipril Action Pathway	0.999999999999667	-3.33202405554053e-13	4	0	0	93	978
SMP00497	Tyrosine hydroxylase deficiency	0.999999999999667	-3.33202405554053e-13	4	0	0	93	978
SMP00479	Plasmalogen Synthesis	0.999999999999667	-3.33202405554053e-13	4	0	0	93	978
SMP00148	Enalapril Action Pathway	0.999999999999667	-3.33202405554053e-13	4	0	0	93	978
SMP00162	Losartan Action Pathway	0.999999999999667	-3.33202405554053e-13	4	0	0	93	978
SMP00451	Refsum Disease	0.999999999999667	-3.33202405554053e-13	4	0	0	93	978
SMP00155	Rescinnamine Action Pathway	0.999999999999667	-3.33202405554053e-13	4	0	0	93	978
SMP00161	Irbesartan Action Pathway	0.999999999999667	-3.33202405554053e-13	4	0	0	93	978
SMP00639	Clomipramine Metabolism Pathway	0.999999999999667	-3.33202405554053e-13	4	0	0	93	978
SMP00146	Captopril Action Pathway	0.999999999999667	-3.33202405554053e-13	4	0	0	93	978
SMP00160	Forasartan Action Pathway	0.999999999999667	-3.33202405554053e-13	4	0	0	93	978
SMP00587	Angiotensin Metabolism	0.999999999999667	-3.33202405554053e-13	4	0	0	93	978
SMP00159	Eprosartan Action Pathway	0.999999999999667	-3.33202405554053e-13	4	0	0	93	978
SMP00147	Cilazapril Action Pathway	0.999999999999667	-3.33202405554053e-13	4	0	0	93	978
SMP00156	Spirapril Action Pathway	0.999999999999667	-3.33202405554053e-13	4	0	0	93	978
SMP00151	Moexipril Action Pathway	0.999999999999667	-3.33202405554053e-13	4	0	0	93	978
SMP00158	Candesartan Action Pathway	0.999999999999667	-3.33202405554053e-13	4	0	0	93	978
SMP00157	Trandolapril Action Pathway	0.999999999999667	-3.33202405554053e-13	4	0	0	93	978
SMP00420	Bevacizumab Action Pathway	1.00000000000001	9.56385578371188e-15	3	0	0	93	978
SMP00653	Rosiglitazone Metabolism Pathway	1.00000000000001	9.56385578371188e-15	3	0	0	93	978
SMP00126	Phenylacetate Metabolism	1.00000000000001	9.56385578371188e-15	3	0	0	93	978
SMP00619	Felodipine Metabolism Pathway	1.00000000000001	9.56385578371188e-15	3	0	0	93	978
SMP00464	Vitamin K Metabolism	1.00000000000001	9.56385578371188e-15	3	0	0	93	978
SMP00626	Desipramine Metabolism Pathway	1.00000000000001	9.56385578371188e-15	3	0	0	93	978
SMP00124	Glycerol Phosphate Shuttle	1.00000000000001	9.56385578371188e-15	3	0	0	93	978
SMP00459	Pyruvaldehyde Degradation	1.00000000000001	9.56385578371188e-15	3	0	0	93	978
SMP00472	Erlotinib Action Pathway	1.00000000000001	9.56385578371188e-15	3	0	0	93	978
SMP00021	Taurine and Hypotaurine Metabolism	1.00000000000051	5.11668230910299e-13	5	0	0	93	978
SMP00454	Repaglinide Action Pathway	1.00000000000051	5.11668230910299e-13	5	0	0	93	978
SMP00641	Doxepin Metabolism Pathway	1.00000000000051	5.11668230910299e-13	5	0	0	93	978
SMP00453	Nateglinide Action Pathway	1.00000000000051	5.11668230910299e-13	5	0	0	93	978
SMP00469	Capecitabine Action Pathway	1.00000000000051	5.11668230910299e-13	5	0	0	93	978
SMP00460	Glibenclamide Action Pathway	1.00000000000051	5.11668230910299e-13	5	0	0	93	978
SMP00607	Capecitabine Metabolism Pathway	1.00000000000051	5.11668230910299e-13	5	0	0	93	978
SMP00643	Pancreas Function	1.00000000000051	5.11668230910299e-13	5	0	0	93	978
SMP00503	Hypophosphatasia	1.00000000000051	5.11668230910299e-13	5	0	0	93	978
SMP00017	Vitamin B6 Metabolism	1.00000000000051	5.11668230910299e-13	5	0	0	93	978
SMP00569	Succinyl CoA: 3-ketoacid CoA transferase deficiency	1.00000000000051	5.11668230910299e-13	5	0	0	93	978
SMP00071	Ketone Body Metabolism	1.00000000000051	5.11668230910299e-13	5	0	0	93	978
SMP00461	Gliclazide Action Pathway	1.00000000000051	5.11668230910299e-13	5	0	0	93	978
SMP00631	Prednisone Metabolism Pathway	1.00000000000092	9.16641762493953e-13	1	0	0	93	978
SMP00265	Abciximab Action Pathway	1.00000000000092	9.16641762493953e-13	1	0	0	93	978
SMP00476	Trastuzumab Action Pathway	1.00000000000092	9.16641762493953e-13	1	0	0	93	978
SMP00593	Enalapril Metabolism Pathway	1.00000000000092	9.16641762493953e-13	1	0	0	93	978
SMP00732	Temocapril Metabolism Pathway	1.00000000000092	9.16641762493953e-13	1	0	0	93	978
SMP00632	Prednisolone Metabolism Pathway	1.00000000000092	9.16641762493953e-13	1	0	0	93	978
SMP00473	Gefitinib Action Pathway	1.00000000000092	9.16641762493953e-13	1	0	0	93	978
SMP00261	Ticlopidine Action Pathway	1.00000000000092	9.16641762493953e-13	1	0	0	93	978
SMP00595	Moexipril Metabolism Pathway	1.00000000000092	9.16641762493953e-13	1	0	0	93	978
SMP00475	Panitumumab Action Pathway	1.00000000000092	9.16641762493953e-13	1	0	0	93	978
SMP00474	Cetuximab Action Pathway	1.00000000000092	9.16641762493953e-13	1	0	0	93	978
SMP00591	Benazepril Metabolism Pathway	1.00000000000092	9.16641762493953e-13	1	0	0	93	978
SMP00597	Ramipril Metabolism Pathway	1.00000000000092	9.16641762493953e-13	1	0	0	93	978
SMP00267	Tirofiban Action Pathway	1.00000000000092	9.16641762493953e-13	1	0	0	93	978
SMP00596	Quinapril Metabolism Pathway	1.00000000000092	9.16641762493953e-13	1	0	0	93	978
SMP00617	Cimetidine Metabolism Pathway	1.00000000000092	9.16641762493953e-13	1	0	0	93	978
SMP00421	Vatalanib Action Pathway	1.00000000000092	9.16641762493953e-13	1	0	0	93	978
SMP00592	Cilazapril Metabolism Pathway	1.00000000000092	9.16641762493953e-13	1	0	0	93	978
SMP00036	D-Arginine and D-Ornithine Metabolism	1.00000000000092	9.16641762493953e-13	1	0	0	93	978
SMP00470	Fluorouracil Action Pathway	1.00000000000092	9.16641762493953e-13	1	0	0	93	978
SMP00611	Ticlopidine Metabolism Pathway	1.00000000000092	9.16641762493953e-13	1	0	0	93	978
SMP00599	Trandolapril Metabolism Pathway	1.00000000000092	9.16641762493953e-13	1	0	0	93	978
SMP00263	Cilostazol Action Pathway	1.00000000000092	9.16641762493953e-13	1	0	0	93	978
SMP00594	Fosinopril Metabolism Pathway	1.00000000000092	9.16641762493953e-13	1	0	0	93	978
SMP00598	Spirapril Metabolism Pathway	1.00000000000092	9.16641762493953e-13	1	0	0	93	978
SMP00264	Dipyridamole (Antiplatelet) Action Pathway	1.00000000000092	9.16641762493953e-13	1	0	0	93	978
SMP00440	Prednisone Action Pathway	1.00000000000092	9.16641762493953e-13	1	0	0	93	978
SMP00638	Levomethadyl Acetate Metabolism Pathway	1.00000000000092	9.16641762493953e-13	1	0	0	93	978
SMP00441	Prednisolone Action Pathway	1.00000000000092	9.16641762493953e-13	1	0	0	93	978
SMP00266	Eptifibatide Action Pathway	1.00000000000092	9.16641762493953e-13	1	0	0	93	978
SMP00608	Fluorouracil Metabolism Pathway	1.00000000000092	9.16641762493953e-13	1	0	0	93	978
SMP00646	Fluoxetine Metabolism Pathway	1.00000000000139	1.3863266197675e-12	6	0	0	93	978
SMP00636	Venlafaxine Metabolism Pathway	1.00000000000139	1.3863266197675e-12	6	0	0	93	978
SMP00628	Nicotine Metabolism Pathway	1.00000000000139	1.3863266197675e-12	6	0	0	93	978
SMP00625	Imipramine Metabolism Pathway	1.00000000000139	1.3863266197675e-12	6	0	0	93	978
SMP00027	Pantothenate and CoA Biosynthesis	1.00000000000139	1.3863266197675e-12	6	0	0	93	978
SMP00634	Carbamazepine Metabolism Pathway	1.00000000000194	1.94379979460202e-12	7	0	0	93	978
SMP00627	Citalopram Metabolism Pathway	1.00000000000194	1.94379979460202e-12	7	0	0	93	978
SMP00682	Leucine Stimulation on Insulin Signaling	1.00000000000194	1.94379979460202e-12	7	0	0	93	978
SMP00487	Hyperphenylalaniemia due to guanosine triphosphate cyclohydrolase deficiency	1.00000000000259	2.58863204404517e-12	8	0	0	93	978
SMP00496	Galactosemia III	1.00000000000259	2.58863204404517e-12	8	0	0	93	978
SMP00005	Pterine Biosynthesis	1.00000000000259	2.58863204404517e-12	8	0	0	93	978
SMP00488	Hyperphenylalaninemia due to 6-pyruvoyltetrahydropterin synthase deficiency (ptps)	1.00000000000259	2.58863204404517e-12	8	0	0	93	978
SMP00495	Galactosemia II (GALK)	1.00000000000259	2.58863204404517e-12	8	0	0	93	978
SMP00010	Nucleotide Sugars Metabolism	1.00000000000259	2.58863204404517e-12	8	0	0	93	978
SMP00605	Ifosfamide Metabolism Pathway	1.00000000000259	2.58863204404517e-12	8	0	0	93	978
SMP00127	Glucose-Alanine Cycle	1.00000000000259	2.58863204404517e-12	8	0	0	93	978
SMP00028	Caffeine Metabolism	1.00000000000259	2.58863204404517e-12	8	0	0	93	978
SMP00073	Butyrate Metabolism	1.00000000000259	2.58863204404517e-12	8	0	0	93	978
SMP00448	Ifosfamide Action Pathway	1.00000000000259	2.58863204404517e-12	8	0	0	93	978
SMP00490	Segawa syndrome	1.00000000000259	2.58863204404517e-12	8	0	0	93	978
SMP00491	Sepiapterin reductase deficiency	1.00000000000259	2.58863204404517e-12	8	0	0	93	978
SMP00486	Dopa-responsive dystonia	1.00000000000259	2.58863204404517e-12	8	0	0	93	978
SMP00489	Hyperphenylalaninemia due to dhpr-deficiency	1.00000000000259	2.58863204404517e-12	8	0	0	93	978
SMP00123	Betaine Metabolism	1.00000000000259	2.58863204404517e-12	8	0	0	93	978
SMP00644	Celecoxib Metabolism Pathway	1.00000000000259	2.58863204404517e-12	8	0	0	93	978
SMP00642	Nevirapine Metabolism Pathway	1.00000000000259	2.58863204404517e-12	8	0	0	93	978
SMP00228	Pantoprazole Action Pathway	1.00000000000371	3.70731847416345e-12	9	0	0	93	978
SMP00232	Cimetidine Action Pathway	1.00000000000371	3.70731847416345e-12	9	0	0	93	978
SMP00351	GABA-Transaminase Deficiency	1.00000000000371	3.70731847416345e-12	9	0	0	93	978
SMP00610	Clopidogrel Metabolism Pathway	1.00000000000371	3.70731847416345e-12	9	0	0	93	978
SMP00225	Esomeprazole Action Pathway	1.00000000000371	3.70731847416345e-12	9	0	0	93	978
SMP00604	Cyclophosphamide Metabolism Pathway	1.00000000000371	3.70731847416345e-12	9	0	0	93	978
SMP00230	Ranitidine Action Pathway	1.00000000000371	3.70731847416345e-12	9	0	0	93	978
SMP00734	Roxatidine acetate Action Pathway	1.00000000000371	3.70731847416345e-12	9	0	0	93	978
SMP00226	Omeprazole Action Pathway	1.00000000000371	3.70731847416345e-12	9	0	0	93	978
SMP00735	Metiamide Action Pathway	1.00000000000371	3.70731847416345e-12	9	0	0	93	978
SMP00260	Clopidogrel Action Pathway	1.00000000000371	3.70731847416345e-12	9	0	0	93	978
SMP00492	Ureidopropionase deficiency	1.00000000000371	3.70731847416345e-12	9	0	0	93	978
SMP00736	Betazole Action Pathway	1.00000000000371	3.70731847416345e-12	9	0	0	93	978
SMP00589	Gastric Acid Production	1.00000000000371	3.70731847416345e-12	9	0	0	93	978
SMP00229	Rabeprazole Action Pathway	1.00000000000371	3.70731847416345e-12	9	0	0	93	978
SMP00233	Nizatidine Action Pathway	1.00000000000371	3.70731847416345e-12	9	0	0	93	978
SMP00493	Carnosinuria- carnosinemia	1.00000000000371	3.70731847416345e-12	9	0	0	93	978
SMP00007	Beta-Alanine Metabolism	1.00000000000371	3.70731847416345e-12	9	0	0	93	978
SMP00227	Lansoprazole Action Pathway	1.00000000000371	3.70731847416345e-12	9	0	0	93	978
SMP00231	Famotidine Action Pathway	1.00000000000371	3.70731847416345e-12	9	0	0	93	978
SMP00246	Pirenzepine Action Pathway	1.00000000000371	3.70731847416345e-12	9	0	0	93	978
SMP00447	Cyclophosphamide Action Pathway	1.00000000000371	3.70731847416345e-12	9	0	0	93	978
SMP00606	Tamoxifen Metabolism Pathway	1.00000000000522	5.21918673670083e-12	10	0	0	93	978
SMP00471	Tamoxifen Action Pathway	1.00000000000522	5.21918673670083e-12	10	0	0	93	978
SMP00624	Methadone Metabolism Pathway	1.00000000000522	5.21918673670083e-12	10	0	0	93	978
SMP00566	17-alpha-hydroxylase deficiency (CYP17)	1.00000000000617	6.16516379716754e-12	11	0	0	93	978
SMP00371	Congenital Lipoid Adrenal Hyperplasia (CLAH) or Lipoid CAH	1.00000000000617	6.16516379716754e-12	11	0	0	93	978
SMP00015	Glutathione Metabolism	1.00000000000617	6.16516379716754e-12	11	0	0	93	978
SMP00575	11-beta-hydroxylase deficiency (CYP11B1)	1.00000000000617	6.16516379716754e-12	11	0	0	93	978
SMP00500	5-oxoprolinase deficiency	1.00000000000617	6.16516379716754e-12	11	0	0	93	978
SMP00187	Glycerol Kinase Deficiency	1.00000000000617	6.16516379716754e-12	11	0	0	93	978
SMP00717	Apparent mineralocorticoid excess syndrome	1.00000000000617	6.16516379716754e-12	11	0	0	93	978
SMP00372	Adrenal Hyperplasia Type 5 or Congenital Adrenal Hyperplasia due to 17 Alpha-hydroxylase Deficiency	1.00000000000617	6.16516379716754e-12	11	0	0	93	978
SMP00391	Insulin Signalling	1.00000000000617	6.16516379716754e-12	11	0	0	93	978
SMP00576	21-hydroxylase deficiency (CYP21)	1.00000000000617	6.16516379716754e-12	11	0	0	93	978
SMP00337	Glutathione Synthetase Deficiency	1.00000000000617	6.16516379716754e-12	11	0	0	93	978
SMP00577	Corticosterone methyl oxidase I deficiency (CMO I)	1.00000000000617	6.16516379716754e-12	11	0	0	93	978
SMP00143	5-Oxoprolinuria	1.00000000000617	6.16516379716754e-12	11	0	0	93	978
SMP00578	Corticosterone methyl oxidase II deficiency - CMO II	1.00000000000617	6.16516379716754e-12	11	0	0	93	978
SMP00501	Gamma-glutamyl-transpeptidase deficiency	1.00000000000617	6.16516379716754e-12	11	0	0	93	978
SMP00530	Familial lipoprotein lipase deficiency	1.00000000000617	6.16516379716754e-12	11	0	0	93	978
SMP00529	D-glyceric acidura	1.00000000000617	6.16516379716754e-12	11	0	0	93	978
SMP00718	3-Beta-Hydroxysteroid Dehydrogenase Deficiency	1.00000000000617	6.16516379716754e-12	11	0	0	93	978
SMP00039	Glycerolipid Metabolism	1.00000000000617	6.16516379716754e-12	11	0	0	93	978
SMP00183	Gamma-Glutamyltransferase Deficiency	1.00000000000617	6.16516379716754e-12	11	0	0	93	978
SMP00373	Adrenal Hyperplasia Type 3 or Congenital Adrenal Hyperplasia due to 21-hydroxylase Deficiency	1.00000000000617	6.16516379716754e-12	11	0	0	93	978
SMP00130	Steroidogenesis	1.00000000000617	6.16516379716754e-12	11	0	0	93	978
SMP00068	Androgen and Estrogen Metabolism	1.00000000000665	6.65151984815313e-12	12	0	0	93	978
SMP00565	Aromatase deficiency	1.00000000000665	6.65151984815313e-12	12	0	0	93	978
SMP00458	Lactose Intolerance	1.00000000000665	6.65151984815313e-12	12	0	0	93	978
SMP00356	17-Beta Hydroxysteroid Dehydrogenase III Deficiency	1.00000000000665	6.65151984815313e-12	12	0	0	93	978
SMP00457	Lactose Degradation	1.00000000000665	6.65151984815313e-12	12	0	0	93	978
SMP00282	Streptokinase Action Pathway	1.00000000000874	8.73736398028584e-12	14	0	0	93	978
SMP00268	Warfarin Action Pathway	1.00000000000874	8.73736398028584e-12	14	0	0	93	978
SMP00276	Argatroban Action Pathway	1.00000000000874	8.73736398028584e-12	14	0	0	93	978
SMP00288	Aprotinin Action Pathway	1.00000000000874	8.73736398028584e-12	14	0	0	93	978
SMP00279	Ximelagatran Action Pathway	1.00000000000874	8.73736398028584e-12	14	0	0	93	978
SMP00281	Anistreplase Action Pathway	1.00000000000874	8.73736398028584e-12	14	0	0	93	978
SMP00656	Dicoumarol Action Pathway	1.00000000000874	8.73736398028584e-12	14	0	0	93	978
SMP00048	Nicotinate and Nicotinamide Metabolism	1.00000000000874	8.73736398028584e-12	14	0	0	93	978
SMP00283	Tenecteplase Action Pathway	1.00000000000874	8.73736398028584e-12	14	0	0	93	978
SMP00269	Acenocoumarol Action Pathway	1.00000000000874	8.73736398028584e-12	14	0	0	93	978
SMP00280	Alteplase Action Pathway	1.00000000000874	8.73736398028584e-12	14	0	0	93	978
SMP00277	Bivalirudin Action Pathway	1.00000000000874	8.73736398028584e-12	14	0	0	93	978
SMP00271	Phenprocoumon Action Pathway	1.00000000000874	8.73736398028584e-12	14	0	0	93	978
SMP00285	Reteplase Action Pathway	1.00000000000874	8.73736398028584e-12	14	0	0	93	978
SMP00278	Lepirudin Action Pathway	1.00000000000874	8.73736398028584e-12	14	0	0	93	978
SMP00655	Phenindione Action Pathway	1.00000000000874	8.73736398028584e-12	14	0	0	93	978
SMP00586	Coagulation 	1.00000000000874	8.73736398028584e-12	14	0	0	93	978
SMP00284	Urokinase Action Pathway	1.00000000000874	8.73736398028584e-12	14	0	0	93	978
SMP00287	Tranexamic Acid Action Pathway	1.00000000000874	8.73736398028584e-12	14	0	0	93	978
SMP00270	Dicumarol Action Pathway	1.00000000000874	8.73736398028584e-12	14	0	0	93	978
SMP00286	Aminocaproic Acid Action Pathway	1.00000000000874	8.73736398028584e-12	14	0	0	93	978
SMP00037	Lysine Degradation	1.00000000000893	8.92948548878189e-12	13	0	0	93	978
SMP00467	Trehalose Degradation	1.00000000000893	8.92948548878189e-12	13	0	0	93	978
SMP00554	Glycogenosis- Type IV. Amylopectinosis	1.00000000000893	8.92948548878189e-12	13	0	0	93	978
SMP00186	Glutaric Aciduria Type I	1.00000000000893	8.92948548878189e-12	13	0	0	93	978
SMP00528	Hyperlysinemia II or Saccharopinuria	1.00000000000893	8.92948548878189e-12	13	0	0	93	978
SMP00527	Hyperlysinemia I- Familial	1.00000000000893	8.92948548878189e-12	13	0	0	93	978
SMP00043	Galactose Metabolism	1.00000000000893	8.92948548878189e-12	13	0	0	93	978
SMP00553	Glycogenosis- Type III. Cori disease	1.00000000000893	8.92948548878189e-12	13	0	0	93	978
SMP00239	Saccharopinuria/Hyperlysinemia II	1.00000000000893	8.92948548878189e-12	13	0	0	93	978
SMP00719	2-aminoadipic 2-oxoadipic aciduria	1.00000000000893	8.92948548878189e-12	13	0	0	93	978
SMP00571	Pyridoxine dependency with seizures	1.00000000000893	8.92948548878189e-12	13	0	0	93	978
SMP00182	Galactosemia	1.00000000000893	8.92948548878189e-12	13	0	0	93	978
SMP00275	Ardeparin Action Pathway	1.00000000000999	9.98507405750966e-12	15	0	0	93	978
SMP00494	Tyrosinemia- transient	1.00000000000999	9.98507405750966e-12	15	0	0	93	978
SMP00273	Fondaparinux Action Pathway	1.00000000000999	9.98507405750966e-12	15	0	0	93	978
SMP00274	Heparin Action Pathway	1.00000000000999	9.98507405750966e-12	15	0	0	93	978
SMP00272	Enoxaparin Action Pathway	1.00000000000999	9.98507405750966e-12	15	0	0	93	978
SMP00218	Tyrosinemia Type I	1.00000000001198	1.19807492841386e-11	17	0	0	93	978
SMP00390	Tay-Sachs Disease	1.00000000001198	1.19807492841386e-11	17	0	0	93	978
SMP00045	Amino Sugar Metabolism	1.00000000001198	1.19807492841386e-11	17	0	0	93	978
SMP00498	Dopamine beta-hydroxylase deficiency	1.00000000001198	1.19807492841386e-11	17	0	0	93	978
SMP00533	Monoamine oxidase-a deficiency (MAO-A)	1.00000000001198	1.19807492841386e-11	17	0	0	93	978
SMP00240	Salla Disease/Infantile Sialic Acid Storage Disease	1.00000000001198	1.19807492841386e-11	17	0	0	93	978
SMP00534	G(M2)-Gangliosidosis: Variant B- Tay-sachs disease	1.00000000001198	1.19807492841386e-11	17	0	0	93	978
SMP00190	Hawkinsinuria	1.00000000001198	1.19807492841386e-11	17	0	0	93	978
SMP00006	Tyrosine Metabolism	1.00000000001198	1.19807492841386e-11	17	0	0	93	978
SMP00216	Sialuria or French Type Sialuria	1.00000000001198	1.19807492841386e-11	17	0	0	93	978
SMP00217	Sialuria or French Type Sialuria	1.00000000001198	1.19807492841386e-11	17	0	0	93	978
SMP00169	Alkaptonuria	1.00000000001198	1.19807492841386e-11	17	0	0	93	978
SMP00525	Fabry disease	1.00000000001678	1.67761455887313e-11	21	0	0	93	978
SMP00526	Krabbe disease	1.00000000001678	1.67761455887313e-11	21	0	0	93	978
SMP00349	Gaucher Disease	1.00000000001678	1.67761455887313e-11	21	0	0	93	978
SMP00034	Sphingolipid Metabolism	1.00000000001678	1.67761455887313e-11	21	0	0	93	978
SMP00347	Metachromatic Leukodystrophy (MLD)	1.00000000001678	1.67761455887313e-11	21	0	0	93	978
SMP00348	Globoid Cell Leukodystrophy	1.00000000001678	1.67761455887313e-11	21	0	0	93	978
SMP00674	Anileridine Action Pathway	1.00000000002024	2.02421375372193e-11	26	0	0	93	978
SMP00411	Hydrocodone Action Pathway	1.00000000002024	2.02421375372193e-11	26	0	0	93	978
SMP00689	Dihydromorphine Action Pathway	1.00000000002024	2.02421375372193e-11	26	0	0	93	978
SMP00687	Naltrexone Action Pathway	1.00000000002024	2.02421375372193e-11	26	0	0	93	978
SMP00675	Diphenoxylate Action Pathway	1.00000000002024	2.02421375372193e-11	26	0	0	93	978
SMP00417	Sufentanil Action Pathway	1.00000000002024	2.02421375372193e-11	26	0	0	93	978
SMP00686	Pentazocine Action Pathway	1.00000000002024	2.02421375372193e-11	26	0	0	93	978
SMP00404	Ropivacaine Action Pathway	1.00000000002024	2.02421375372193e-11	26	0	0	93	978
SMP00425	Escitalopram Action Pathway	1.00000000002024	2.02421375372193e-11	26	0	0	93	978
SMP00679	3-Methylthiofentanyl Action Pathway	1.00000000002024	2.02421375372193e-11	26	0	0	93	978
SMP00681	Ethylmorphine Action Pathway	1.00000000002024	2.02421375372193e-11	26	0	0	93	978
SMP00684	Buprenorphine Action Pathway	1.00000000002024	2.02421375372193e-11	26	0	0	93	978
SMP00672	Propoxyphene Action Pathway	1.00000000002024	2.02421375372193e-11	26	0	0	93	978
SMP00690	Ketobemidone  Action Pathway	1.00000000002024	2.02421375372193e-11	26	0	0	93	978
SMP00392	Benzocaine Action Pathway	1.00000000002024	2.02421375372193e-11	26	0	0	93	978
SMP00410	Hydromorphone Action Pathway	1.00000000002024	2.02421375372193e-11	26	0	0	93	978
SMP00399	Mepivacaine Action Pathway	1.00000000002024	2.02421375372193e-11	26	0	0	93	978
SMP00678	Methadyl Acetate Action Pathway	1.00000000002024	2.02421375372193e-11	26	0	0	93	978
SMP00025	Phospholipid Biosynthesis	1.00000000002024	2.02421375372193e-11	26	0	0	93	978
SMP00416	Remifentanil Action Pathway	1.00000000002024	2.02421375372193e-11	26	0	0	93	978
SMP00671	Tramadol Action Action Pathway	1.00000000002024	2.02421375372193e-11	26	0	0	93	978
SMP00393	Bupivacaine Action Pathway	1.00000000002024	2.02421375372193e-11	26	0	0	93	978
SMP00396	Dibucaine Action Pathway	1.00000000002024	2.02421375372193e-11	26	0	0	93	978
SMP00415	Fentanyl Action Pathway	1.00000000002024	2.02421375372193e-11	26	0	0	93	978
SMP00673	Levorphanol Action Pathway	1.00000000002024	2.02421375372193e-11	26	0	0	93	978
SMP00401	Prilocaine Action Pathway	1.00000000002024	2.02421375372193e-11	26	0	0	93	978
SMP00685	Alvimopan Action Pathway	1.00000000002024	2.02421375372193e-11	26	0	0	93	978
SMP00400	Oxybuprocaine Action Pathway	1.00000000002024	2.02421375372193e-11	26	0	0	93	978
SMP00394	Chloroprocaine Action Pathway	1.00000000002024	2.02421375372193e-11	26	0	0	93	978
SMP00414	Carfentanil Action Pathway	1.00000000002024	2.02421375372193e-11	26	0	0	93	978
SMP00397	Levobupivacaine Action Pathway	1.00000000002024	2.02421375372193e-11	26	0	0	93	978
SMP00676	Dezocine Action Pathway	1.00000000002024	2.02421375372193e-11	26	0	0	93	978
SMP00413	Alfentanil Action Pathway	1.00000000002024	2.02421375372193e-11	26	0	0	93	978
SMP00395	Cocaine Action Pathway	1.00000000002024	2.02421375372193e-11	26	0	0	93	978
SMP00412	Oxymorphone Action Pathway	1.00000000002024	2.02421375372193e-11	26	0	0	93	978
SMP00688	Naloxone Action Pathway	1.00000000002024	2.02421375372193e-11	26	0	0	93	978
SMP00403	Proparacaine Action Pathway	1.00000000002024	2.02421375372193e-11	26	0	0	93	978
SMP00677	Levomethadyl Acetate Action Action Pathway	1.00000000002024	2.02421375372193e-11	26	0	0	93	978
SMP00683	Levallorphan Action Pathway	1.00000000002024	2.02421375372193e-11	26	0	0	93	978
SMP00402	Procaine Action Pathway	1.00000000002024	2.02421375372193e-11	26	0	0	93	978
SMP00680	Dimethylthiambutene Action Pathway	1.00000000002024	2.02421375372193e-11	26	0	0	93	978
SMP00409	Oxycodone Action Pathway	1.00000000002024	2.02421375372193e-11	26	0	0	93	978
SMP00691	Nalbuphine Action Pathway	1.00000000002128	2.12788216190284e-11	27	0	0	93	978
SMP00423	Desipramine Action Pathway	1.00000000002128	2.12788216190284e-11	27	0	0	93	978
SMP00398	Lidocaine (Local Anaesthetic) Action Pathway	1.00000000002264	2.26353296582347e-11	28	0	0	93	978
SMP00405	Codeine Action Pathway	1.0000000000232	2.32008843142758e-11	29	0	0	93	978
SMP00407	Heroin Action Pathway	1.0000000000232	2.32008843142758e-11	29	0	0	93	978
SMP00426	Fluoxetine Action Pathway	1.00000000002345	2.34453552707281e-11	31	0	0	93	978
SMP00422	Imipramine Action Pathway	1.0000000000242	2.4203499963237e-11	30	0	0	93	978
SMP00424	Citalopram Action Pathway	1.00000000002546	2.54617593302927e-11	32	0	0	93	978
SMP00431	Nicotine Action Pathway	1.00000000002546	2.54617593302927e-11	32	0	0	93	978
SMP00408	Methadone Action Pathway	1.00000000002546	2.54617593302927e-11	32	0	0	93	978
